Page last updated: 2024-12-05

chalcone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

trans-chalcone : The trans-isomer of chalcone. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID637760
CHEMBL ID7976
CHEBI ID48965
CHEBI ID27618
SCHEMBL ID27580
MeSH IDM0003983

Synonyms (129)

Synonym
BIDD:ER0232
AC-16892
EN300-16057
1-phenyl-2-benzoylethylene
2-benzylideneacetophenone
cinnamophenone
benzylidenecetophenone
nsc-4523
1-benzoyl-1-phenylethene
1,3-diphenyl-1-propen-3-one
.beta.-phenylacrylophenone
1-benzoyl-2-phenylethene
3-phenylacrylophenone
wln: rv1u1r
2-benzalacetophenone
.beta.-benzoylstyrene
chalkone
phenyl styryl ketone
.alpha.-benzylideneacetophenone
acrylophenone, 3-phenyl-
nsc4523
benzalacetophenone
2-propen-1-one, 1,3-diphenyl-, (e)-
trans-chalcone
nsc-26612
nsc26612
1,3-diphenylpropenone
benzylidene acetophenone
nsc 26612
alpha-benzylideneacetophenone
beta-phenylacrylophenone
beta-benzoylstyrene
phenyl 2-phenylvinyl ketone
ai3-00946
ccris 2213
styryl phenyl ketone
einecs 202-330-2
phenyl (e)-2-phenylethenyl ketone
einecs 210-383-8
ccris 3778
(2e)-1,3-diphenyl-2-propen-1-one
(e)-chalcone
(e)-benzylideneacetophenone
phenyl (e)--2-phenylethenyl ketone
1,3-diphenylprop-2-en-1-one
trans-benzalacetophenone
chalkon
phenyl trans-styryl ketone
CHEBI:48965 ,
CHEBI:27618 ,
(e)-1,3-diphenyl-2-propen-1-one
trans-benzylideneacetophenone
benzylideneacetophenone
94-41-7
chalcone ,
1,3-diphenyl-2-propen-1-one
C01484
nsc-167107
nsc167107
614-47-1
2-propen-1-one,3-diphenyl-, (e)-
2-propen-1-one, 1,3-diphenyl-
(e)-1,3-diphenylprop-2-en-1-one
trans-chalcone-d12, 98 atom % d
trans-chalcone, 97%
smr000059029
MLS000069600 ,
(2e)-1,3-diphenylprop-2-en-1-one
1,3 diphenyl 2 propen 1 one
STK257430
(e)-3-phenyl-1-phenylprop-2-en-1-one
phenylstyryl ketone
1,3-diphenyl-2-propenone, >=98.0% (gc)
5173133B-0B1C-46FB-8DFF-976669EE9D5B
chembl7976 ,
chalcone, 13
cid_637760
bdbm29143
substituted chalcone, 5j
chalcone 1
(e)-1,3-diphenyl-propenone
AE-641/00372002
BMSE000704
1,3-diphenyl-2-propenone
AKOS001041518
A833233
NCGC00018232-03
nsc 167107
unii-5s5a2q39hx
5s5a2q39hx ,
(e)-1,3-diphenyl-prop-2-en-1-one
BBL010497
HMS2235P17
S5845
phenyl (e)-styryl ketone
2-propen-1-one, 1,3-diphenyl-, (2e)-
chalcone [mi]
chalcone (e)-form [mi]
chalcone, (e)-
AKOS025310645
SCHEMBL27580
1-benzoyl-2-phenylethylene
benzylidenacetophenone
.omega.-benzylideneacetophenone
J-200119
STR06550
OPERA_ID_1389
mfcd00003082
b-benzoylstyrene
a-benzylideneacetophenone
3-phenyl-acrylophenone
1, 3-diphenyl-1-propen-3-one
chalcone (acd/name 4.0)
SR-01000000156-2
sr-01000000156
DTXSID20873536
b-phenylacrylophenone
HY-121054
BCP14123
Q899416
AMY37401
CS-0079373
AC7897
D70211
A852077
Z46028346
chalcedony8108
chalcone (e)-form
dtxcid80809654

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" During this study, amide 15 was thus identified as the best drug-candidate to for further investigation as a potential drug in search for new, safe and effective antimalarial drugs."( Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides.
N'da, DD; Smit, FJ, 2014
)
0.4
" This adverse potential has never been captured in animal models, and the responsible compound(s) remains to be determined."( Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice.
Leitzman, P; Narayanapillai, SC; O'Sullivan, MG; Xing, C, 2014
)
0.4
" The safety outcomes included any adverse events during 90 days after treatment."( Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial.
Cai, YF; Gao, M; Hu, MZ; Li, L; Lin, AJ; Liu, LM; Lu, H; Song, HQ; Wang, X; Wu, QM; Zhou, HF; Zhou, ZY, 2020
)
0.56
" No significant difference was reported among the 4 groups in any specific adverse events (P>0."( Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial.
Cai, YF; Gao, M; Hu, MZ; Li, L; Lin, AJ; Liu, LM; Lu, H; Song, HQ; Wang, X; Wu, QM; Zhou, HF; Zhou, ZY, 2020
)
0.56
"HSYAI was safe and well-tolerated at all doses for treating AIS patients with BSS."( Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial.
Cai, YF; Gao, M; Hu, MZ; Li, L; Lin, AJ; Liu, LM; Lu, H; Song, HQ; Wang, X; Wu, QM; Zhou, HF; Zhou, ZY, 2020
)
0.56
" Behavioral, physiological, biochemical, and histological toxic effects were evaluated."( Toxicity assessment of synthetic chalcones with antileishmanial potential in BALB/c mice.
Adaui, V; Arévalo, J; Cancino, K; Castillo, D; Castro, I; Jullian, V; Sauvain, M; Yauri, C,
)
0.13
"The LD50 for all three chalcones was greater than 550 mg/kg of body weight."( Toxicity assessment of synthetic chalcones with antileishmanial potential in BALB/c mice.
Adaui, V; Arévalo, J; Cancino, K; Castillo, D; Castro, I; Jullian, V; Sauvain, M; Yauri, C,
)
0.13
" However, several problems, such as low dose tolerance and highly toxic to the brain and colon, low solubility unsuitable for intravenous (i."( Structure optimization of an F-indole-chalcone (FC116) on 4-methoxyphenyl group and therapeutic potential against colorectal cancers with low cytotoxicity.
Du, B; Liu, X; Luan, X; Zhang, W; Zhuang, C, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
"A high-performance liquid chromatographic method was developed for the simultaneous determination and pharmacokinetic studies of safflor yellow A, puerarin, 3'-methoxyl-puerarin, and puerarinapioside in the plasma and tissues of rats that had been administered with the traditional Chinese medicine (TCM) preparation Naodesheng via the caudal vein."( HPLC determination of safflor yellow A and three active isoflavones from TCM Naodesheng in rat plasma and tissues and its application to pharmacokinetic studies.
Bi, K; Gao, X; Yu, Z; Zhao, Y, 2007
)
0.34
" However, there have been few detailed pharmacokinetic studies about HSYA on human beings."( Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers.
Jia, Y; Tian, Y; Wen, A; Yang, J; Yang, Z, 2009
)
0.35
"The aim was to investigate the pharmacokinetic characteristics of HSYA in healthy Chinese female volunteers."( Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers.
Jia, Y; Tian, Y; Wen, A; Yang, J; Yang, Z, 2009
)
0.35
" Various pharmacokinetic parameters were estimated from the plasma concentration versus time data using non-compartmental methods."( Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers.
Jia, Y; Tian, Y; Wen, A; Yang, J; Yang, Z, 2009
)
0.35
"In this study, the pharmacokinetic properties of HSYA are based on first-order kinetics over the dose range tested."( Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers.
Jia, Y; Tian, Y; Wen, A; Yang, J; Yang, Z, 2009
)
0.35
" The differences of pharmacokinetic properties between normal and blood stasis syndrome rats were seldom reported."( Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats.
Jia, YY; Li, Y; Qiao, Y; Tian, Y; Wen, AD; Yang, J; Yang, ZF, 2010
)
0.36
" Various pharmacokinetic parameters were estimated from the plasma concentration versus time data using non-compartmental methods."( Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats.
Jia, YY; Li, Y; Qiao, Y; Tian, Y; Wen, AD; Yang, J; Yang, ZF, 2010
)
0.36
" The pharmacokinetic parameters were calculated with 3p97 program."( [Studies on pharmacokinetics of hydroxysafflor yellow A in Carthamus tinctorius and its compound preparation in rat].
Cao, X; Fang, J; Feng, X; Ouyang, Z; Tang, J, 2011
)
0.37
"To investigate the pharmacokinetic effect of Sappan Lignum on hydroxysafflor yellow A (HSYA) in Carthami Flos."( [Pharmacokinetic effect of Sappan Lignum on hydroxysafflor yellow A in Carthami Flos].
Chen, XM; Liu, QS; Peng, LR; Wang, SX; Wang, XW; Xia, L; Zhang, P; Zheng, XH; Zuo, Y, 2013
)
0.39
"In vivo pharmacokinetic models of HSYA were two-compartment open models in both of the Carthami Flos group and the Carthami Flos combined with Sappan Lignum group."( [Pharmacokinetic effect of Sappan Lignum on hydroxysafflor yellow A in Carthami Flos].
Chen, XM; Liu, QS; Peng, LR; Wang, SX; Wang, XW; Xia, L; Zhang, P; Zheng, XH; Zuo, Y, 2013
)
0.39
"To study on the effects of Achyranthes bidentata on Tongsaimai pellets main active ingredients chlorogenic acid, isoliquiritin, harpagoside and glycyrrhizin in rats in vivo pharmacokinetic behaviors, a method for the simultaneous determination of chlorogenic acid, isoliquiritin, harpagoside and liquiritigenin in rat plasma was established by UPLC-MS/MS."( [Studies on effects of Achyranthes bidentata on tongsaimai pellets main active ingredients chlorogenic acid, isoliquiritin, harpagoside and glycyrrhizin in vivo pharmacokinetics].
Bi, XL; Cheng, J; Di, LQ; Kang, A; Li, JS; Shan, JJ; Zhao, XL, 2014
)
0.4
" However, there is a lack of information about the complete clinical pharmacokinetic profiles of HSYA following the administration of its pure preparations."( Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers.
Ju, WZ; Li, CY; Liu, F; Wang, XX; Xu, MJ; Yin, JG; Zhang, J; Zou, JD, 2015
)
0.42
" Both Cmax and AUC of HSYA in male volunteers were generally lower than that in females."( Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers.
Ju, WZ; Li, CY; Liu, F; Wang, XX; Xu, MJ; Yin, JG; Zhang, J; Zou, JD, 2015
)
0.42
" The effects of protocatechuic aldehyde and hydroxysafflor yellow A against the pharmacodynamic action may be related with their level in vivo, and their plasma concentration was positively related to the PAF and GMP-140 contents."( [Pharmacokinetics-pharmacodynamics correlation of protocatechuic aldehyde and hydroxysafflor yellow A alone or their combination use in rats with hyperlipidemia].
Fan, HJ; Jin, WF; Li, M; Li, XH; Yu, L; Zhang, YY; Zhou, J, 2017
)
0.46
" Furthermore, Caco-2 cell transport and fecal hydrolysis were investigated to explain the altered pharmacokinetic properties."( Influence of Jiegeng on Pharmacokinetic Properties of Flavonoids and Saponins in Gancao.
Di, L; Ji, J; Kang, A; Mao, Y; Peng, L; Shan, J; Shen, C; Wu, H; Xie, T; Xu, J, 2017
)
0.46
" This study aims to investigate the pharmacokinetic differences between single and combined medication of PAL and HSYA and analyze the interaction of the above effective components in hyperlipidemia rats."( Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia.
Fan, H; Jin, W; Li, M; Li, X; Zhang, Y; Zhou, J, 2018
)
0.48
" However, the pharmacokinetic characteristics of its major bioactive components in rats under different physiological and pathological states are not clear."( Comparative pharmacokinetics of nine major bioactive components in normal and ulcerative colitis rats after oral administration of Lizhong decoction extracts by UPLC-TQ-MS/MS.
Cui, X; Duan, JA; Jiang, S; Qian, DW; Shen, Y, 2019
)
0.51
" Furthermore, the method was successfully applied for pharmacokinetic study of these seven components in rat serum after oral administration of NDS."( Validated LC-MS/MS method for simultaneous quantification of seven components of Naodesheng in rat serum after oral administration and its application to a pharmacokinetic study.
Kang, J; Liang, S; Luo, L; Qi, Y; Zhao, W, 2019
)
0.51
"Twenty-four prototype components in HQD and 17 metabolites were identified in humans, and the pharmacokinetic characteristics of 14 components were elucidated."( Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis.
Jiang, J; Li, Y; Liu, P; Ma, Y; Meng, C; Shi, R; Wang, T; Wang, Y; Wu, J; Yuan, W; Zeng, J; Zhang, H; Zhong, J; Zhu, L, 2021
)
0.62
" However, its pharmacokinetic characteristics in normal and diabetic cardiomyopathy (DCM) mice remain unknown."( Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice.
Cao, Y; Jiang, R; Li, F; Wang, S; Yao, R; Zhang, X, 2021
)
0.62
" Determination of the pharmacokinetic variables at the preliminary step of drug development for any drug candidates is an essential component of in vivo antimalarial efficacy tests."( Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits.
Batovska, DI; Medhi, B; Prakash, A; Sehgal, A; Sehgal, R; Sinha, S, 2021
)
0.62
"In vivo pharmacokinetic studies of these three derivatives were performed on New Zealand White rabbits."( Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits.
Batovska, DI; Medhi, B; Prakash, A; Sehgal, A; Sehgal, R; Sinha, S, 2021
)
0.62
"The PK-PD model of the combined administration of HSYA and CA was successfully established in rats, and the differences in pharmacodynamic and pharmacokinetic properties between the normal and cerebral ischemic rats were evaluated."( Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study.
Bao, Y; Chen, Q; He, Y; Wan, J; Yang, J; Yu, L; Zhang, Y, 2022
)
0.72

Compound-Compound Interactions

A total of 30 chalcone analogues was synthesized via a base catalyzed Claisen Schmidt condensation. They were screened for their in vitro antibacterial activity against Methicillin-sensitive Staphylococcus aureus (MSSA) alone or in combination with non beta-lactam antibiotics namely ciprofloxacin, chloramphenicol, erythromycin, vancomycin and gentamicin.

ExcerptReferenceRelevance
" We determined the therapeutic effects of sofalcone and polaprezinc when combined with rabeprazole, amoxicillin and clarithromycin for Helicobacter pylori infection."( Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Ohnita, K; Wen, CY, 2005
)
0.33
"The addition of sofalcone, but not polaprezinc, significantly increased the cure rate of H pylori infection when combined with the rabeprazole-amoxicillin-clarithromycin regimen."( Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Ohnita, K; Wen, CY, 2005
)
0.33
" A few potent chalcones were selected for their antimalarial interaction in combination with artemisinin in vitro."( Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparum in vitro.
Awasthi, SK; Bhasin, VK; Bhattacharya, A; Mishra, LC; Sharma, M, 2009
)
0.35
"A total of 30 chalcone analogues was synthesized via a base catalyzed Claisen Schmidt condensation and screened for their in vitro antibacterial activity against Methicillin-sensitive Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) alone or in combination with non beta-lactam antibiotics namely ciprofloxacin, chloramphenicol, erythromycin, vancomycin, doxycycline and gentamicin."( Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
Do, TH; Huynh, TN; Ngo, TD; Thai, KM; Tran, CD; Tran, NC; Tran, TD, 2012
)
0.38
"To evaluate the clinical efficacy of safflower yellow injection combined with conventional therapy in treating unstable angina pectoris."( Safflower yellow injection combined with conventional therapy in treating unstable angina pectoris: a meta-analysis.
Kong, D; Liu, Y; Xia, W; Xiao, L; Yang, G; Yuan, D; Zhang, Z, 2013
)
0.39
" The study aimed at investigating the relationship between thrombin and carthami flos through a high-performance thrombin affinity chromatography combined with a high-performance liquid chromatography-tandem mass spectrometry system."( Rapid screening and identification of anticoagulation component from carthami flos by two-dimensional thrombin affinity chromatography combined with HPLC-MS/MS.
Deng, Z; Hou, X; Pan, X; Qiao, Y; Shi, Y; Wang, S; Wu, C, 2021
)
0.62
"A simple and rapid instantaneous nebulization dispersive liquid-phase microextraction method was developed, and combined with high-performance liquid chromatography for determination of the contents of seven analytes in traditional Chinese medicines."( Application of instantaneous nebulization dispersive liquid-phase microextraction combined with HPLC for the determination of chalcone and isoflavone in traditional Chinese medicines.
Chen, X; Hu, S; Liu, N; Wang, LL; Wang, RQ; Xing, RR; Yang, L, 2023
)
0.91

Bioavailability

The therapeutic use of chalcones is limited because of their lower bioavailability and rapid metabolic clearance from biological system. The aim of this study is to synthesize chalcone-polyamine conjugates in order to enhance bioavailability. It was also verified that the chal Cones 1-4 are well absorbed in the intestine, but with a decrease in their bioavailability, resulting in a low volume of distribution in the blood plasma.

ExcerptReferenceRelevance
"Oral doses of the peripheral vasodilator mecinarone (6809 MD), administered as the 14C-compound, were well absorbed from the gastrointestinal tract of rats, dogs and humans."( The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.
Chasseaud, LF; Darragh, A; Hawkins, DR; O'Kelly, A; Weston, KT, 1980
)
0.26
" The blood profiles for both administration routes, demonstrated that the bioavailability of the active principle was good."( Absorption and elimination of (14C) hesperidin methylchalcone in the rat.
Bonnaud, B; Chanal, JL; Cousse, H; Marignan, R; Sicart, MT, 1981
)
0.26
"The objective of the present investigation was to clarify the mechanism by which Labrafac Lipophile WL 1349 (WL 1349) enhanced the oral bioavailability (BA) of hydroxysafflor yellow A (HSYA), the representative low permeable hydrophilic (biopharmaceutic classification system (BCS) Class III) drug."( Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
Ping, Q; Sun, M; Wang, S, 2008
)
0.35
" However, compared to other structurally similar phytochemicals like garcinol and curcumin, the therapeutic use of chalcones is limited because of their lower bioavailability and rapid metabolic clearance from biological system."( Fluorinated 2'-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities.
Ahmad, A; Dandawate, P; Deshpande, J; Oswal, N; Padhye, S; Rub, RA; Sarkar, FH; Swamy, KV, 2010
)
0.36
"A microemulsion is an effective formulation for improving the oral bioavailability of poorly soluble drugs."( Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.
Jia, J; Lu, Y; Ping, Q; Qi, J; Song, Y; Wu, W; Zhang, Z; Zhuang, J, 2011
)
0.37
"The microemulsion increased the oral bioavailability of hydroxysafflor yellow A which was highly water-soluble but very poorly permeable."( Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.
Jia, J; Lu, Y; Ping, Q; Qi, J; Song, Y; Wu, W; Zhang, Z; Zhuang, J, 2011
)
0.37
"These results suggested that digestion of the microemulsion by pancreatic lipase plays an important role in enhancing oral bioavailability of water-soluble drugs."( Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.
Jia, J; Lu, Y; Ping, Q; Qi, J; Song, Y; Wu, W; Zhang, Z; Zhuang, J, 2011
)
0.37
" The results indicated that the other herbs improved the absorption of hydroxysafflor yellow A and increased the bioavailability of hydroxysafflor yellow A significantly."( [Studies on pharmacokinetics of hydroxysafflor yellow A in Carthamus tinctorius and its compound preparation in rat].
Cao, X; Fang, J; Feng, X; Ouyang, Z; Tang, J, 2011
)
0.37
" Both enhanced uptake in Caco-2 cells monolayer and increased bioavailability in rats for HSYA nanoparticles indicated that the formulation could improve bioavailability of HSYA significantly after oral administration both in vitro and in vivo."( Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles.
Gao, JQ; Han, M; Lv, LZ; Tong, CQ; Yu, J, 2013
)
0.39
"), is a hydrophilic drug with low oral bioavailability (BA)."( A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
Li, ZP; Ma, GN; Mei, XG; Wang, S; Xie, XY; Yu, FL, 2015
)
0.42
" These changes resulted in enhanced oral bioavailability and a superior pharmacodynamic effect in vivo."( Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy.
Abou-Gharbia, M; Allaway, G; Biswal, S; Childers, W; Gordon, J; Jones, B; Korzekwa, K; Lounsbury, N; Mateo, G; Papaiahgari, S; Teijaro, C; Thimmulappa, RK; Ye, M, 2015
)
0.42
"Alkaline phosphatase (AP) and ecto-5'-nucleotidase (e5'NT) belong to same family that hydrolyze the extracellular nucleotides and ensure the bioavailability of nucleotides and nucleosides at purinergic receptors."( Synthesis, characterization and biological evaluation of novel chalcone sulfonamide hybrids as potent intestinal alkaline phosphatase inhibitors.
Ejaz, SA; Iqbal, J; Khan, S; Lecka, J; Nisa, ZU; Saeed, A; Sévigny, J; Siddique, MN, 2017
)
0.46
"The aim of this study is to synthesize chalcone-polyamine conjugates in order to enhance bioavailability and selectivity of chalcone core towards cancer cells, using polyamine-based vectors."( Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
Champavier, Y; Duroux, JL; Fagnère, C; Fidanzi-Dugas, C; Gamond, A; Laurent, A; Léger, DY; Liagre, B; Pinon, A; Pouget, C; Rioux, B; Semaan, J; Sol, V, 2017
)
0.46
" Pharmacokinetics results suggested that the bioavailability of liquiritin, isoliquiritin, glycyrrhizin and its metabolite, glycyrrhetinic acid, could be improved while bioavailability of liquiritigenin and isoliquiritigenin deteriorated when co-administered with Jiegeng."( Influence of Jiegeng on Pharmacokinetic Properties of Flavonoids and Saponins in Gancao.
Di, L; Ji, J; Kang, A; Mao, Y; Peng, L; Shan, J; Shen, C; Wu, H; Xie, T; Xu, J, 2017
)
0.46
" Curcumin has been examined in a number of clinical studies with limited success, mainly owing to limited bioavailability and rapid metabolism."( Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin.
Deck, LM; Hunsaker, LA; Royer, RE; Vander Jagt, DL; Vander Jagt, TA; Whalen, LJ, 2018
)
0.48
" The surface chemistry of dendrimers is of great relevance as end groups of these nanocarriers can be easily modified to improve the bioavailability and sustained release of the cargo."( Influence of dendrimer surface chemistry and pH on the binding and release pattern of chalcone studied by molecular dynamics simulations.
Badalkhani-Khamseh, F; Ebrahim-Habibi, A; Hadipour, NL, 2019
)
0.51
" However, the poor stability, solubility, in vivo bioavailability and weak activity of CU greatly limit its clinical application."( Recent advances of analogues of curcumin for treatment of cancer.
Pi, C; Wei, Y; Ye, Y; Zhao, L; Zhao, S, 2019
)
0.51
"The oral bioavailability of carthamin was 41."( [Screening and identification of potential targets of carthamin against sepsis].
Chen, G; Guo, S; Xu, Y, 2021
)
0.62
"The aim of this study was to synthesize chalcone-polyamine conjugates in order to enhance bioavailability and selectivity of chalcone core towards cancer cells, using polyamine-based vectors."( Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.
Barette, C; Champavier, Y; Fagnère, C; Gamond, A; Laurent, A; Liagre, B; Martin, F; Pinon, A; Pouget, C; Rioux, B; Sol, V, 2021
)
0.62
" The results indicate a very low bioavailability of these derivatives."( Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits.
Batovska, DI; Medhi, B; Prakash, A; Sehgal, A; Sehgal, R; Sinha, S, 2021
)
0.62
" It was also verified that the chalcones 1-4 are well absorbed in the intestine, but with a decrease in their bioavailability, resulting in a low volume of distribution in the blood plasma, in addition to having a mild CNS activity."( In vitro and in silico studies of chalcones derived from natural acetophenone inhibitors of NorA and MepA multidrug efflux pumps in Staphylococcus aureus.
Barbosa, CRS; Campina, FF; Coutinho, HDM; de Araújo Neto, JB; Dos Santos, HS; Freitas, TS; Marinho, ES; Nogueira, CES; Pereira, RLS; Rocha, JE; Silva, MMC; Teixeira, AMR; Xavier, JC, 2021
)
0.62
" However, the pharmacokinetics, biosafety, and bioavailability of ISL remain to be further investigated."( Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases.
Chen, Z; Ding, W; Liu, Y; Lu, T; Yang, X, 2024
)
1.44

Dosage Studied

ExcerptRelevanceReference
" The dosage was 3 X 2 capsules per day."( [Experiences in the use of Essaven capsules in the treatment of venous leg diseases. Results of a double-blind study].
Neumann-Mangoldt, P, 1979
)
0.26
") given 30 min prior to SU-88 dosing blocked this protective effect, whereas it was not affected when indomethacin was given 30 min after the SU-88 dosing."( Cytoprotective effect of SU-88, an anti-ulcer agent, in the rat.
Kyogoku, K; Mori, Y; Nakazima, M; Shinozaki, A; Suwa, T, 1984
)
0.27
"1 mg x L(-1) SY dosage dependently."( [Study on the antioxidative effect of Safflor Yellow].
Jin, M; Li, JR; Wu, W, 2004
)
0.32
" In a subsequent experiment, we measured the dose-response effect on the clonogenic growth of UACC-812 breast cancer cells by pre-incubating the fibroblasts with varying concentrations of butein (10 microg/ml-1."( The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts.
Chorn, G; Samoszuk, M; Tan, J, 2005
)
0.33
" Western blot results illustrated that in the same dosage and incubation time, DMC could down-regulate the level of Bcl-2 protein and did not influence the expression of Bax protein."( Induction of apoptosis in K562 human leukemia cells by 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone.
Liu, JW; Lu, YH; Qian, F; Wei, DZ; Ye, CL, 2005
)
0.33
") treatment at the same dosage for 10 d to ICR mice bearing sarcoma 180 caused a significant suppression in tumor weight by 33."( Anti-angiogenic and anti-tumor activities of 2'-hydroxy-4'-methoxychalcone.
Jung, SH; Kim, YS; Lee, YS; Lim, SS; Ohuchi, K; Shin, KH, 2006
)
0.33
" The preliminary bioassay showed that some of the chalcone analogues exhibited good in vivo fungicidal activities against Pseudoperoniospora cubensis and Sphaerotheca fuliginea at the dosage of 200 microg mL(-1)."( Synthesis and fungicidal evaluation of novel chalcone-based strobilurin analogues.
Huang, W; Liu, CL; Wang, YZ; Yang, GF; Zhao, PL, 2007
)
0.34
" When the Hill's coefficients describing the dose-response relations of drugs were different, based on the concept of dose equivalence, the equations of additivity surfaces which can be applied to assess the interaction between three drugs were derived."( Material basis for inhibition of Dragon's Blood on evoked discharges of wide dynamic range neurons in spinal dorsal horn of rats.
Chen, S; Guo, M; Liu, X, 2008
)
0.35
" Then nude mice were divided into 4 groups at random: model group, control group, high or low dosage of HSYA group."( [Effects of hydroxy safflor yellow A on blood vessel and mRNA expression with VEGF and bFGF of transplantation tumor with gastric adenocarcinoma cell line BGC-823 in nude mice].
Deng, X; Gao, X; Liu, C; Liu, L; Qian, L; Wu, L; Xi, S; Xie, H; Zhang, J; Zhang, Q, 2009
)
0.35
" Furthermore, 5b could significantly suppress the progression of carrageenan-induced hind paw edema compared to indomethacin at a dosage of 10 mg/kg/day, and dose-dependently ameliorated the development of adjuvant-induced arthritis (AIA) validated by arthritic scores and H&E staining of joints."( Rational design, synthesis, and pharmacological properties of pyranochalcone derivatives as potent anti-inflammatory agents.
Cao, D; Chen, J; Chen, L; Deng, C; Li, X; Liang, X; Ma, L; Peng, A; Peng, F; Qiu, J; Ran, Y; Wang, G; Wei, Y; Xiang, M; Xie, C; Yang, Z; Ye, H, 2012
)
0.38
" These results indicate that the method can be successfully used in order to assay SCD in a nanoemulsion dosage form, and that this formulation has a protective effect over SCD degradation."( Development of a stability-indicating LC method for determination of a synthetic chalcone derivative in a nanoemulsion dosage form and identification of the main photodegradation product by LC-MS.
Andrighetti-Frohner, CR; Barreto, F; Deponti, VB; Koester, LS; Mattos, CB; Nunes, RJ; Simões, CM; Steindel, M; Teixeira, HF, 2012
)
0.38
" The results demonstrated that HSYA improved the viability of BV2 cells 12h after OGD with the profound dosage at 100mg/L by MTT assay."( Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation.
Chen, C; Chen, Z; Han, L; Li, J; Lu, M; Xu, Y; Zhang, M; Zhang, S, 2013
)
0.39
" Gender difference should be considered for dosage recommendation in the clinic."( Pharmacokinetic profiles of hydroxysafflor yellow A following intravenous administration of its pure preparations in healthy Chinese volunteers.
Ju, WZ; Li, CY; Liu, F; Wang, XX; Xu, MJ; Yin, JG; Zhang, J; Zou, JD, 2015
)
0.42
" HSYA treatment with a dosage of 8 mg/kg or higher markedly downregulated the expression of the JAK2-mediated signaling that was activated in response to ischemic insult, while it also promoted the expression of SOCS3 coordinately."( Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways.
Cao, X; Chen, H; Duan, Y; He, W; Lai, Z; Liu, Z; Tao, J; Xu, C; Yu, L; Zhang, J; Zhang, Q; Zhao, Z, 2020
)
0.56
" The study provided additional insights into the development of drugs for ischemic stroke as well as the design of appropriate dosing regimens."( Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study.
Bao, Y; Chen, Q; He, Y; Wan, J; Yang, J; Yu, L; Zhang, Y, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 3.2.1.1 (alpha-amylase) inhibitorAn EC 3.2.1.* (glycosidase) inhibitor that interferes with the action of alpha-amylase (EC 3.2.1.1).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
chalconeA member of the class of chalcones that is acetophenone in which one of the methyl hydrogens has been replaced by a benzylidene group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (63)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency79.43280.631035.7641100.0000AID504339
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency4.46680.125919.1169125.8920AID2549
LuciferasePhotinus pyralis (common eastern firefly)Potency6.19670.007215.758889.3584AID411; AID588342
thioredoxin reductaseRattus norvegicus (Norway rat)Potency100.00000.100020.879379.4328AID588453
phosphopantetheinyl transferaseBacillus subtilisPotency19.95260.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency20.25500.004110.890331.5287AID504466; AID504467
TDP1 proteinHomo sapiens (human)Potency14.58100.000811.382244.6684AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency14.12540.180013.557439.8107AID1460
thioredoxin glutathione reductaseSchistosoma mansoniPotency28.18380.100022.9075100.0000AID485364
Smad3Homo sapiens (human)Potency35.48130.00527.809829.0929AID588855
regulator of G-protein signaling 4Homo sapiens (human)Potency70.79460.531815.435837.6858AID504845
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency2.51190.28189.721235.4813AID2326
pyruvate kinaseLeishmania mexicana mexicanaPotency15.84890.398113.744731.6228AID1721; AID1722
IDH1Homo sapiens (human)Potency16.36010.005210.865235.4813AID686970
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency44.66840.016525.307841.3999AID602332
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency19.79290.354828.065989.1251AID504847; AID602199; AID602200; AID602201; AID602202
chromobox protein homolog 1Homo sapiens (human)Potency63.09570.006026.168889.1251AID540317
DNA polymerase eta isoform 1Homo sapiens (human)Potency89.12510.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency22.38720.050127.073689.1251AID588590
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency7.94330.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency7.94330.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency7.94330.15855.287912.5893AID540303
gemininHomo sapiens (human)Potency17.80300.004611.374133.4983AID624296; AID624297
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)Potency31.62280.058010.694926.6086AID602310
DNA dC->dU-editing enzyme APOBEC-3F isoform aHomo sapiens (human)Potency6.30960.025911.239831.6228AID602313
lamin isoform A-delta10Homo sapiens (human)Potency22.38720.891312.067628.1838AID1487
Endothelin receptor type BRattus norvegicus (Norway rat)Potency15.84890.562315.160931.6228AID1721
Endothelin-1 receptorRattus norvegicus (Norway rat)Potency15.84890.562315.160931.6228AID1721
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
perilipin-5Homo sapiens (human)IC50 (µMol)4.24500.98503.45659.4680AID504319
perilipin-1Homo sapiens (human)IC50 (µMol)4.19400.92503.30339.6190AID504317
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)IC50 (µMol)4.21950.92503.58289.6190AID504317; AID504319
Thioredoxin reductase 1, cytoplasmicRattus norvegicus (Norway rat)IC50 (µMol)36.55000.27201.82606.0000AID1441014; AID1441015
Dihydrofolate reductaseHomo sapiens (human)IC50 (µMol)100.00000.00060.87267.3000AID1292016
Pancreatic triacylglycerol lipaseSus scrofa (pig)IC50 (µMol)84.41000.00401.10246.5000AID1693046
AcetylcholinesteraseTetronarce californica (Pacific electric ray)IC50 (µMol)109.00000.00570.42855.1200AID1799680
Tubulin beta-4A chainHomo sapiens (human)IC50 (µMol)620.00000.00051.968010.0000AID1511072
CholinesteraseHomo sapiens (human)IC50 (µMol)87.00000.00001.559910.0000AID1142531
Tubulin beta chainHomo sapiens (human)IC50 (µMol)620.00000.00052.052910.0000AID1511072
Tubulin alpha-3C chainHomo sapiens (human)IC50 (µMol)620.00000.00051.955510.0000AID1511072
Androgen receptorRattus norvegicus (Norway rat)IC50 (µMol)64.56540.00101.979414.1600AID255211
Tumor necrosis factor receptor superfamily member 1AHomo sapiens (human)IC50 (µMol)23.00007.00007.00007.0000AID226858
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)1.41000.00002.37899.7700AID1798967
Prostaglandin G/H synthase 1Mus musculus (house mouse)IC50 (µMol)22.10000.00072.08445.1000AID161998
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)471.78670.00001.89149.5700AID1057563; AID1798967; AID349912
Amine oxidase [flavin-containing] BHomo sapiens (human)Ki0.05600.00061.777110.0000AID1768350
Polyunsaturated fatty acid 5-lipoxygenaseMus musculus (house mouse)IC50 (µMol)12.20000.00800.15750.4000AID6764
Tubulin alpha-1B chainHomo sapiens (human)IC50 (µMol)620.00000.00051.955510.0000AID1511072
Tubulin alpha-4A chainHomo sapiens (human)IC50 (µMol)620.00000.00051.955510.0000AID1511072
Tubulin beta-4B chainHomo sapiens (human)IC50 (µMol)620.00000.00051.968010.0000AID1511072
Prostaglandin G/H synthase 2Mus musculus (house mouse)IC50 (µMol)11.20000.00050.40086.2000AID160570
Tubulin beta-3 chainHomo sapiens (human)IC50 (µMol)620.00000.00051.894510.0000AID1511072
Tubulin beta-2A chainHomo sapiens (human)IC50 (µMol)620.00000.00051.968010.0000AID1511072
Tubulin beta-8 chainHomo sapiens (human)IC50 (µMol)620.00000.00051.968010.0000AID1511072
Tubulin alpha-3E chainHomo sapiens (human)IC50 (µMol)620.00000.00051.955510.0000AID1511072
Tubulin alpha-1A chainHomo sapiens (human)IC50 (µMol)620.00000.00051.955510.0000AID1511072
Sortase AStreptococcus mutansIC50 (µMol)5.00005.00005.00005.0000AID1557212
Tubulin alpha-1C chainHomo sapiens (human)IC50 (µMol)620.00000.00051.955510.0000AID1511072
Tubulin beta-6 chainHomo sapiens (human)IC50 (µMol)620.00000.00051.968010.0000AID1511072
Tubulin beta-2B chainHomo sapiens (human)IC50 (µMol)620.00000.00051.968010.0000AID1511072
Tubulin beta-1 chainHomo sapiens (human)IC50 (µMol)620.00000.00051.987010.0000AID1511072
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Substance-P receptorCavia porcellus (domestic guinea pig)CD31.00000.90004.50009.8000AID144377
Quinone oxidoreductaseMus musculus (house mouse)CD31.00000.20002.74219.8000AID144377
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (152)

Processvia Protein(s)Taxonomy
tetrahydrobiopterin biosynthetic processDihydrofolate reductaseHomo sapiens (human)
one-carbon metabolic processDihydrofolate reductaseHomo sapiens (human)
negative regulation of translationDihydrofolate reductaseHomo sapiens (human)
axon regenerationDihydrofolate reductaseHomo sapiens (human)
response to methotrexateDihydrofolate reductaseHomo sapiens (human)
dihydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate biosynthetic processDihydrofolate reductaseHomo sapiens (human)
folic acid metabolic processDihydrofolate reductaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityDihydrofolate reductaseHomo sapiens (human)
regulation of removal of superoxide radicalsDihydrofolate reductaseHomo sapiens (human)
negative regulation of microtubule polymerizationTubulin beta-4A chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-4A chainHomo sapiens (human)
mitotic cell cycleTubulin beta-4A chainHomo sapiens (human)
xenobiotic metabolic processCholinesteraseHomo sapiens (human)
learningCholinesteraseHomo sapiens (human)
negative regulation of cell population proliferationCholinesteraseHomo sapiens (human)
neuroblast differentiationCholinesteraseHomo sapiens (human)
peptide hormone processingCholinesteraseHomo sapiens (human)
response to alkaloidCholinesteraseHomo sapiens (human)
cocaine metabolic processCholinesteraseHomo sapiens (human)
negative regulation of synaptic transmissionCholinesteraseHomo sapiens (human)
response to glucocorticoidCholinesteraseHomo sapiens (human)
response to folic acidCholinesteraseHomo sapiens (human)
choline metabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic processCholinesteraseHomo sapiens (human)
odontoblast differentiationTubulin beta chainHomo sapiens (human)
microtubule-based processTubulin beta chainHomo sapiens (human)
cytoskeleton-dependent intracellular transportTubulin beta chainHomo sapiens (human)
natural killer cell mediated cytotoxicityTubulin beta chainHomo sapiens (human)
regulation of synapse organizationTubulin beta chainHomo sapiens (human)
spindle assemblyTubulin beta chainHomo sapiens (human)
cell divisionTubulin beta chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta chainHomo sapiens (human)
mitotic cell cycleTubulin beta chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin alpha-3C chainHomo sapiens (human)
mitotic cell cycleTubulin alpha-3C chainHomo sapiens (human)
aortic valve developmentTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
pulmonary valve developmentTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
negative regulation of extracellular matrix constituent secretionTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
transcription by RNA polymerase IITumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
prostaglandin metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
inflammatory responseTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
negative regulation of cardiac muscle hypertrophyTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathwayTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
cytokine-mediated signaling pathwayTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
tumor necrosis factor-mediated signaling pathwayTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of amide metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
defense response to bacteriumTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of lipid metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IITumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
negative regulation of inflammatory responseTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of inflammatory responseTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
cellular response to mechanical stimulusTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
protein localization to plasma membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of execution phase of apoptosisTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
positive regulation of apoptotic process involved in morphogenesisTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
regulation of establishment of endothelial barrierTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
regulation of membrane lipid metabolic processTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of cell adhesionStromal cell-derived factor 1Homo sapiens (human)
positive regulation of T cell migrationStromal cell-derived factor 1Homo sapiens (human)
response to hypoxiaStromal cell-derived factor 1Homo sapiens (human)
neuron migrationStromal cell-derived factor 1Homo sapiens (human)
positive regulation of endothelial cell proliferationStromal cell-derived factor 1Homo sapiens (human)
intracellular calcium ion homeostasisStromal cell-derived factor 1Homo sapiens (human)
chemotaxisStromal cell-derived factor 1Homo sapiens (human)
defense responseStromal cell-derived factor 1Homo sapiens (human)
immune responseStromal cell-derived factor 1Homo sapiens (human)
cell adhesionStromal cell-derived factor 1Homo sapiens (human)
signal transductionStromal cell-derived factor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
blood circulationStromal cell-derived factor 1Homo sapiens (human)
regulation of actin polymerization or depolymerizationStromal cell-derived factor 1Homo sapiens (human)
adult locomotory behaviorStromal cell-derived factor 1Homo sapiens (human)
response to virusStromal cell-derived factor 1Homo sapiens (human)
telencephalon cell migrationStromal cell-derived factor 1Homo sapiens (human)
animal organ regenerationStromal cell-derived factor 1Homo sapiens (human)
positive regulation of dopamine secretionStromal cell-derived factor 1Homo sapiens (human)
integrin activationStromal cell-derived factor 1Homo sapiens (human)
chemokine (C-X-C motif) ligand 12 signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
CXCL12-activated CXCR4 signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
response to peptide hormoneStromal cell-derived factor 1Homo sapiens (human)
positive regulation of neuron differentiationStromal cell-derived factor 1Homo sapiens (human)
positive regulation of axon extension involved in axon guidanceStromal cell-derived factor 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painStromal cell-derived factor 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painStromal cell-derived factor 1Homo sapiens (human)
cell chemotaxisStromal cell-derived factor 1Homo sapiens (human)
chemokine-mediated signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
positive regulation of monocyte chemotaxisStromal cell-derived factor 1Homo sapiens (human)
positive regulation of calcium ion importStromal cell-derived factor 1Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damageStromal cell-derived factor 1Homo sapiens (human)
negative regulation of leukocyte tethering or rollingStromal cell-derived factor 1Homo sapiens (human)
positive regulation of vasculature developmentStromal cell-derived factor 1Homo sapiens (human)
response to ultrasoundStromal cell-derived factor 1Homo sapiens (human)
cellular response to chemokineStromal cell-derived factor 1Homo sapiens (human)
negative regulation of dendritic cell apoptotic processStromal cell-derived factor 1Homo sapiens (human)
positive regulation of cell migrationStromal cell-derived factor 1Homo sapiens (human)
induction of positive chemotaxisStromal cell-derived factor 1Homo sapiens (human)
axon guidanceStromal cell-derived factor 1Homo sapiens (human)
microtubule cytoskeleton organizationTubulin alpha-1B chainHomo sapiens (human)
microtubule-based processTubulin alpha-1B chainHomo sapiens (human)
cytoskeleton-dependent intracellular transportTubulin alpha-1B chainHomo sapiens (human)
cell divisionTubulin alpha-1B chainHomo sapiens (human)
cellular response to interleukin-4Tubulin alpha-1B chainHomo sapiens (human)
mitotic cell cycleTubulin alpha-1B chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin alpha-4A chainHomo sapiens (human)
mitotic cell cycleTubulin alpha-4A chainHomo sapiens (human)
natural killer cell mediated cytotoxicityTubulin beta-4B chainHomo sapiens (human)
mitotic cell cycleTubulin beta-4B chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-4B chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-3 chainHomo sapiens (human)
axon guidanceTubulin beta-3 chainHomo sapiens (human)
netrin-activated signaling pathwayTubulin beta-3 chainHomo sapiens (human)
dorsal root ganglion developmentTubulin beta-3 chainHomo sapiens (human)
mitotic cell cycleTubulin beta-3 chainHomo sapiens (human)
cerebral cortex developmentTubulin beta-2A chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-2A chainHomo sapiens (human)
mitotic cell cycleTubulin beta-2A chainHomo sapiens (human)
oocyte maturationTubulin beta-8 chainHomo sapiens (human)
spindle assembly involved in female meiosisTubulin beta-8 chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-8 chainHomo sapiens (human)
mitotic cell cycleTubulin beta-8 chainHomo sapiens (human)
biological_processTubulin alpha-3E chainHomo sapiens (human)
mitotic cell cycleTubulin alpha-3E chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin alpha-3E chainHomo sapiens (human)
neuron migrationTubulin alpha-1A chainHomo sapiens (human)
startle responseTubulin alpha-1A chainHomo sapiens (human)
intracellular protein transportTubulin alpha-1A chainHomo sapiens (human)
microtubule-based processTubulin alpha-1A chainHomo sapiens (human)
centrosome cycleTubulin alpha-1A chainHomo sapiens (human)
smoothened signaling pathwayTubulin alpha-1A chainHomo sapiens (human)
memoryTubulin alpha-1A chainHomo sapiens (human)
adult locomotory behaviorTubulin alpha-1A chainHomo sapiens (human)
visual learningTubulin alpha-1A chainHomo sapiens (human)
response to mechanical stimulusTubulin alpha-1A chainHomo sapiens (human)
glial cell differentiationTubulin alpha-1A chainHomo sapiens (human)
gene expressionTubulin alpha-1A chainHomo sapiens (human)
dentate gyrus developmentTubulin alpha-1A chainHomo sapiens (human)
cerebellar cortex morphogenesisTubulin alpha-1A chainHomo sapiens (human)
pyramidal neuron differentiationTubulin alpha-1A chainHomo sapiens (human)
cerebral cortex developmentTubulin alpha-1A chainHomo sapiens (human)
cytoskeleton-dependent intracellular transportTubulin alpha-1A chainHomo sapiens (human)
response to tumor necrosis factorTubulin alpha-1A chainHomo sapiens (human)
locomotory exploration behaviorTubulin alpha-1A chainHomo sapiens (human)
microtubule polymerizationTubulin alpha-1A chainHomo sapiens (human)
forebrain morphogenesisTubulin alpha-1A chainHomo sapiens (human)
homeostasis of number of cells within a tissueTubulin alpha-1A chainHomo sapiens (human)
regulation of synapse organizationTubulin alpha-1A chainHomo sapiens (human)
synapse organizationTubulin alpha-1A chainHomo sapiens (human)
cell divisionTubulin alpha-1A chainHomo sapiens (human)
neuron apoptotic processTubulin alpha-1A chainHomo sapiens (human)
motor behaviorTubulin alpha-1A chainHomo sapiens (human)
cellular response to calcium ionTubulin alpha-1A chainHomo sapiens (human)
organelle transport along microtubuleTubulin alpha-1A chainHomo sapiens (human)
neuron projection arborizationTubulin alpha-1A chainHomo sapiens (human)
response to L-glutamateTubulin alpha-1A chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin alpha-1A chainHomo sapiens (human)
mitotic cell cycleTubulin alpha-1A chainHomo sapiens (human)
microtubule-based processTubulin alpha-1C chainHomo sapiens (human)
cytoskeleton-dependent intracellular transportTubulin alpha-1C chainHomo sapiens (human)
cell divisionTubulin alpha-1C chainHomo sapiens (human)
mitotic cell cycleTubulin alpha-1C chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin alpha-1C chainHomo sapiens (human)
mitotic cell cycleTubulin beta-6 chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-6 chainHomo sapiens (human)
neuron migrationTubulin beta-2B chainHomo sapiens (human)
microtubule-based processTubulin beta-2B chainHomo sapiens (human)
cerebral cortex developmentTubulin beta-2B chainHomo sapiens (human)
modulation of chemical synaptic transmissionTubulin beta-2B chainHomo sapiens (human)
positive regulation of axon guidanceTubulin beta-2B chainHomo sapiens (human)
embryonic brain developmentTubulin beta-2B chainHomo sapiens (human)
mitotic cell cycleTubulin beta-2B chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-2B chainHomo sapiens (human)
platelet formationTubulin beta-1 chainHomo sapiens (human)
thyroid gland developmentTubulin beta-1 chainHomo sapiens (human)
microtubule polymerizationTubulin beta-1 chainHomo sapiens (human)
spindle assemblyTubulin beta-1 chainHomo sapiens (human)
thyroid hormone transportTubulin beta-1 chainHomo sapiens (human)
platelet aggregationTubulin beta-1 chainHomo sapiens (human)
mitotic cell cycleTubulin beta-1 chainHomo sapiens (human)
microtubule cytoskeleton organizationTubulin beta-1 chainHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (48)

Processvia Protein(s)Taxonomy
mRNA regulatory element binding translation repressor activityDihydrofolate reductaseHomo sapiens (human)
mRNA bindingDihydrofolate reductaseHomo sapiens (human)
dihydrofolate reductase activityDihydrofolate reductaseHomo sapiens (human)
folic acid bindingDihydrofolate reductaseHomo sapiens (human)
NADPH bindingDihydrofolate reductaseHomo sapiens (human)
sequence-specific mRNA bindingDihydrofolate reductaseHomo sapiens (human)
NADP bindingDihydrofolate reductaseHomo sapiens (human)
GTPase activityTubulin beta-4A chainHomo sapiens (human)
calcium ion bindingTubulin beta-4A chainHomo sapiens (human)
protein bindingTubulin beta-4A chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-4A chainHomo sapiens (human)
GTP bindingTubulin beta-4A chainHomo sapiens (human)
amyloid-beta bindingCholinesteraseHomo sapiens (human)
catalytic activityCholinesteraseHomo sapiens (human)
acetylcholinesterase activityCholinesteraseHomo sapiens (human)
cholinesterase activityCholinesteraseHomo sapiens (human)
protein bindingCholinesteraseHomo sapiens (human)
hydrolase activity, acting on ester bondsCholinesteraseHomo sapiens (human)
enzyme bindingCholinesteraseHomo sapiens (human)
choline bindingCholinesteraseHomo sapiens (human)
identical protein bindingCholinesteraseHomo sapiens (human)
GTPase activityTubulin beta chainHomo sapiens (human)
structural molecule activityTubulin beta chainHomo sapiens (human)
protein bindingTubulin beta chainHomo sapiens (human)
protein domain specific bindingTubulin beta chainHomo sapiens (human)
ubiquitin protein ligase bindingTubulin beta chainHomo sapiens (human)
GTPase activating protein bindingTubulin beta chainHomo sapiens (human)
MHC class I protein bindingTubulin beta chainHomo sapiens (human)
protein-containing complex bindingTubulin beta chainHomo sapiens (human)
metal ion bindingTubulin beta chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta chainHomo sapiens (human)
GTP bindingTubulin beta chainHomo sapiens (human)
hydrolase activityTubulin alpha-3C chainHomo sapiens (human)
metal ion bindingTubulin alpha-3C chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin alpha-3C chainHomo sapiens (human)
GTP bindingTubulin alpha-3C chainHomo sapiens (human)
tumor necrosis factor receptor activityTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
protein bindingTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
tumor necrosis factor bindingTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
signaling receptor bindingStromal cell-derived factor 1Homo sapiens (human)
integrin bindingStromal cell-derived factor 1Homo sapiens (human)
protein bindingStromal cell-derived factor 1Homo sapiens (human)
chemokine activityStromal cell-derived factor 1Homo sapiens (human)
growth factor activityStromal cell-derived factor 1Homo sapiens (human)
chemokine receptor bindingStromal cell-derived factor 1Homo sapiens (human)
CXCR chemokine receptor bindingStromal cell-derived factor 1Homo sapiens (human)
double-stranded RNA bindingTubulin alpha-1B chainHomo sapiens (human)
GTPase activityTubulin alpha-1B chainHomo sapiens (human)
structural molecule activityTubulin alpha-1B chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin alpha-1B chainHomo sapiens (human)
protein bindingTubulin alpha-1B chainHomo sapiens (human)
GTP bindingTubulin alpha-1B chainHomo sapiens (human)
ubiquitin protein ligase bindingTubulin alpha-1B chainHomo sapiens (human)
protein bindingTubulin alpha-4A chainHomo sapiens (human)
hydrolase activityTubulin alpha-4A chainHomo sapiens (human)
protein kinase bindingTubulin alpha-4A chainHomo sapiens (human)
metal ion bindingTubulin alpha-4A chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin alpha-4A chainHomo sapiens (human)
GTP bindingTubulin alpha-4A chainHomo sapiens (human)
double-stranded RNA bindingTubulin beta-4B chainHomo sapiens (human)
GTPase activityTubulin beta-4B chainHomo sapiens (human)
protein bindingTubulin beta-4B chainHomo sapiens (human)
MHC class I protein bindingTubulin beta-4B chainHomo sapiens (human)
metal ion bindingTubulin beta-4B chainHomo sapiens (human)
unfolded protein bindingTubulin beta-4B chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-4B chainHomo sapiens (human)
GTP bindingTubulin beta-4B chainHomo sapiens (human)
GTPase activityTubulin beta-3 chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-3 chainHomo sapiens (human)
protein bindingTubulin beta-3 chainHomo sapiens (human)
GTP bindingTubulin beta-3 chainHomo sapiens (human)
peptide bindingTubulin beta-3 chainHomo sapiens (human)
metal ion bindingTubulin beta-3 chainHomo sapiens (human)
netrin receptor bindingTubulin beta-3 chainHomo sapiens (human)
GTPase activityTubulin beta-2A chainHomo sapiens (human)
protein bindingTubulin beta-2A chainHomo sapiens (human)
metal ion bindingTubulin beta-2A chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-2A chainHomo sapiens (human)
GTP bindingTubulin beta-2A chainHomo sapiens (human)
molecular_functionTubulin beta-8 chainHomo sapiens (human)
GTPase activityTubulin beta-8 chainHomo sapiens (human)
metal ion bindingTubulin beta-8 chainHomo sapiens (human)
GTP bindingTubulin beta-8 chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-8 chainHomo sapiens (human)
molecular_functionTubulin alpha-3E chainHomo sapiens (human)
protein bindingTubulin alpha-3E chainHomo sapiens (human)
hydrolase activityTubulin alpha-3E chainHomo sapiens (human)
metal ion bindingTubulin alpha-3E chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin alpha-3E chainHomo sapiens (human)
GTP bindingTubulin alpha-3E chainHomo sapiens (human)
structural molecule activityTubulin alpha-1A chainHomo sapiens (human)
protein bindingTubulin alpha-1A chainHomo sapiens (human)
hydrolase activityTubulin alpha-1A chainHomo sapiens (human)
identical protein bindingTubulin alpha-1A chainHomo sapiens (human)
protein-containing complex bindingTubulin alpha-1A chainHomo sapiens (human)
metal ion bindingTubulin alpha-1A chainHomo sapiens (human)
protein heterodimerization activityTubulin alpha-1A chainHomo sapiens (human)
GTP bindingTubulin alpha-1A chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin alpha-1A chainHomo sapiens (human)
structural molecule activityTubulin alpha-1C chainHomo sapiens (human)
protein bindingTubulin alpha-1C chainHomo sapiens (human)
hydrolase activityTubulin alpha-1C chainHomo sapiens (human)
metal ion bindingTubulin alpha-1C chainHomo sapiens (human)
GTP bindingTubulin alpha-1C chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin alpha-1C chainHomo sapiens (human)
molecular_functionTubulin beta-6 chainHomo sapiens (human)
GTPase activityTubulin beta-6 chainHomo sapiens (human)
protein bindingTubulin beta-6 chainHomo sapiens (human)
metal ion bindingTubulin beta-6 chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-6 chainHomo sapiens (human)
GTP bindingTubulin beta-6 chainHomo sapiens (human)
GTPase activityTubulin beta-2B chainHomo sapiens (human)
protein bindingTubulin beta-2B chainHomo sapiens (human)
metal ion bindingTubulin beta-2B chainHomo sapiens (human)
protein heterodimerization activityTubulin beta-2B chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-2B chainHomo sapiens (human)
GTP bindingTubulin beta-2B chainHomo sapiens (human)
GTPase activityTubulin beta-1 chainHomo sapiens (human)
metal ion bindingTubulin beta-1 chainHomo sapiens (human)
structural constituent of cytoskeletonTubulin beta-1 chainHomo sapiens (human)
GTP bindingTubulin beta-1 chainHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (49)

Processvia Protein(s)Taxonomy
mitochondrionDihydrofolate reductaseHomo sapiens (human)
cytosolDihydrofolate reductaseHomo sapiens (human)
mitochondrionDihydrofolate reductaseHomo sapiens (human)
nucleusTubulin beta-4A chainHomo sapiens (human)
cytosolTubulin beta-4A chainHomo sapiens (human)
microtubuleTubulin beta-4A chainHomo sapiens (human)
axonemeTubulin beta-4A chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-4A chainHomo sapiens (human)
internode region of axonTubulin beta-4A chainHomo sapiens (human)
neuronal cell bodyTubulin beta-4A chainHomo sapiens (human)
myelin sheathTubulin beta-4A chainHomo sapiens (human)
intercellular bridgeTubulin beta-4A chainHomo sapiens (human)
extracellular exosomeTubulin beta-4A chainHomo sapiens (human)
mitotic spindleTubulin beta-4A chainHomo sapiens (human)
microtubuleTubulin beta-4A chainHomo sapiens (human)
cytoplasmTubulin beta-4A chainHomo sapiens (human)
extracellular regionCholinesteraseHomo sapiens (human)
nuclear envelope lumenCholinesteraseHomo sapiens (human)
endoplasmic reticulum lumenCholinesteraseHomo sapiens (human)
blood microparticleCholinesteraseHomo sapiens (human)
plasma membraneCholinesteraseHomo sapiens (human)
extracellular spaceCholinesteraseHomo sapiens (human)
extracellular regionTubulin beta chainHomo sapiens (human)
nucleusTubulin beta chainHomo sapiens (human)
nuclear envelope lumenTubulin beta chainHomo sapiens (human)
cytoplasmTubulin beta chainHomo sapiens (human)
cytosolTubulin beta chainHomo sapiens (human)
cytoskeletonTubulin beta chainHomo sapiens (human)
microtubuleTubulin beta chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta chainHomo sapiens (human)
azurophil granule lumenTubulin beta chainHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleTubulin beta chainHomo sapiens (human)
cell bodyTubulin beta chainHomo sapiens (human)
membrane raftTubulin beta chainHomo sapiens (human)
intercellular bridgeTubulin beta chainHomo sapiens (human)
extracellular exosomeTubulin beta chainHomo sapiens (human)
mitotic spindleTubulin beta chainHomo sapiens (human)
protein-containing complexTubulin beta chainHomo sapiens (human)
cytoplasmTubulin beta chainHomo sapiens (human)
microtubuleTubulin beta chainHomo sapiens (human)
nucleusTubulin alpha-3C chainHomo sapiens (human)
microtubule cytoskeletonTubulin alpha-3C chainHomo sapiens (human)
microtubuleTubulin alpha-3C chainHomo sapiens (human)
cytoplasmTubulin alpha-3C chainHomo sapiens (human)
Golgi membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
extracellular regionTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
extracellular spaceTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
plasma membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
cell surfaceTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
membraneTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
membrane raftTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
tumor necrosis factor receptor superfamily complexTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
receptor complexTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
membrane raftTumor necrosis factor receptor superfamily member 1AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
extracellular regionStromal cell-derived factor 1Homo sapiens (human)
collagen-containing extracellular matrixStromal cell-derived factor 1Homo sapiens (human)
extracellular exosomeStromal cell-derived factor 1Homo sapiens (human)
external side of plasma membraneStromal cell-derived factor 1Homo sapiens (human)
microtubule cytoskeletonTubulin alpha-1B chainHomo sapiens (human)
microtubuleTubulin alpha-1B chainHomo sapiens (human)
cytoplasmic microtubuleTubulin alpha-1B chainHomo sapiens (human)
microtubule cytoskeletonTubulin alpha-1B chainHomo sapiens (human)
microtubuleTubulin alpha-1B chainHomo sapiens (human)
cytoplasmTubulin alpha-1B chainHomo sapiens (human)
extracellular regionTubulin alpha-4A chainHomo sapiens (human)
cytosolTubulin alpha-4A chainHomo sapiens (human)
cytoskeletonTubulin alpha-4A chainHomo sapiens (human)
microtubuleTubulin alpha-4A chainHomo sapiens (human)
microtubule cytoskeletonTubulin alpha-4A chainHomo sapiens (human)
extracellular exosomeTubulin alpha-4A chainHomo sapiens (human)
cytoplasmTubulin alpha-4A chainHomo sapiens (human)
microtubuleTubulin alpha-4A chainHomo sapiens (human)
extracellular regionTubulin beta-4B chainHomo sapiens (human)
nucleusTubulin beta-4B chainHomo sapiens (human)
cytosolTubulin beta-4B chainHomo sapiens (human)
cytoskeletonTubulin beta-4B chainHomo sapiens (human)
microtubuleTubulin beta-4B chainHomo sapiens (human)
axonemal microtubuleTubulin beta-4B chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-4B chainHomo sapiens (human)
azurophil granule lumenTubulin beta-4B chainHomo sapiens (human)
intercellular bridgeTubulin beta-4B chainHomo sapiens (human)
extracellular exosomeTubulin beta-4B chainHomo sapiens (human)
mitotic spindleTubulin beta-4B chainHomo sapiens (human)
extracellular vesicleTubulin beta-4B chainHomo sapiens (human)
microtubuleTubulin beta-4B chainHomo sapiens (human)
cytoplasmTubulin beta-4B chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-3 chainHomo sapiens (human)
nucleusTubulin beta-3 chainHomo sapiens (human)
microtubuleTubulin beta-3 chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-3 chainHomo sapiens (human)
lamellipodiumTubulin beta-3 chainHomo sapiens (human)
filopodiumTubulin beta-3 chainHomo sapiens (human)
axonTubulin beta-3 chainHomo sapiens (human)
dendriteTubulin beta-3 chainHomo sapiens (human)
growth coneTubulin beta-3 chainHomo sapiens (human)
neuronal cell bodyTubulin beta-3 chainHomo sapiens (human)
intercellular bridgeTubulin beta-3 chainHomo sapiens (human)
extracellular exosomeTubulin beta-3 chainHomo sapiens (human)
cell peripheryTubulin beta-3 chainHomo sapiens (human)
mitotic spindleTubulin beta-3 chainHomo sapiens (human)
microtubuleTubulin beta-3 chainHomo sapiens (human)
cytoplasmTubulin beta-3 chainHomo sapiens (human)
nucleusTubulin beta-2A chainHomo sapiens (human)
microtubuleTubulin beta-2A chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-2A chainHomo sapiens (human)
intercellular bridgeTubulin beta-2A chainHomo sapiens (human)
extracellular exosomeTubulin beta-2A chainHomo sapiens (human)
mitotic spindleTubulin beta-2A chainHomo sapiens (human)
extracellular vesicleTubulin beta-2A chainHomo sapiens (human)
cytoplasmTubulin beta-2A chainHomo sapiens (human)
microtubuleTubulin beta-2A chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-8 chainHomo sapiens (human)
intercellular bridgeTubulin beta-8 chainHomo sapiens (human)
extracellular exosomeTubulin beta-8 chainHomo sapiens (human)
mitotic spindleTubulin beta-8 chainHomo sapiens (human)
meiotic spindleTubulin beta-8 chainHomo sapiens (human)
microtubuleTubulin beta-8 chainHomo sapiens (human)
cytoplasmTubulin beta-8 chainHomo sapiens (human)
nucleusTubulin alpha-3E chainHomo sapiens (human)
microtubule cytoskeletonTubulin alpha-3E chainHomo sapiens (human)
microtubuleTubulin alpha-3E chainHomo sapiens (human)
cytoplasmTubulin alpha-3E chainHomo sapiens (human)
condensed chromosomeTubulin alpha-1A chainHomo sapiens (human)
nucleusTubulin alpha-1A chainHomo sapiens (human)
cytosolTubulin alpha-1A chainHomo sapiens (human)
microtubuleTubulin alpha-1A chainHomo sapiens (human)
axonemal microtubuleTubulin alpha-1A chainHomo sapiens (human)
plasma membraneTubulin alpha-1A chainHomo sapiens (human)
microtubule cytoskeletonTubulin alpha-1A chainHomo sapiens (human)
neuromuscular junctionTubulin alpha-1A chainHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleTubulin alpha-1A chainHomo sapiens (human)
recycling endosomeTubulin alpha-1A chainHomo sapiens (human)
extracellular exosomeTubulin alpha-1A chainHomo sapiens (human)
microtubuleTubulin alpha-1A chainHomo sapiens (human)
cytoplasmTubulin alpha-1A chainHomo sapiens (human)
nucleusTubulin alpha-1C chainHomo sapiens (human)
microtubuleTubulin alpha-1C chainHomo sapiens (human)
cytoplasmic microtubuleTubulin alpha-1C chainHomo sapiens (human)
microtubule cytoskeletonTubulin alpha-1C chainHomo sapiens (human)
vesicleTubulin alpha-1C chainHomo sapiens (human)
membrane raftTubulin alpha-1C chainHomo sapiens (human)
microtubuleTubulin alpha-1C chainHomo sapiens (human)
cytoplasmTubulin alpha-1C chainHomo sapiens (human)
nucleusTubulin beta-6 chainHomo sapiens (human)
microtubuleTubulin beta-6 chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-6 chainHomo sapiens (human)
intercellular bridgeTubulin beta-6 chainHomo sapiens (human)
extracellular exosomeTubulin beta-6 chainHomo sapiens (human)
mitotic spindleTubulin beta-6 chainHomo sapiens (human)
cytoplasmTubulin beta-6 chainHomo sapiens (human)
microtubuleTubulin beta-6 chainHomo sapiens (human)
nucleusTubulin beta-2B chainHomo sapiens (human)
microtubuleTubulin beta-2B chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-2B chainHomo sapiens (human)
intercellular bridgeTubulin beta-2B chainHomo sapiens (human)
mitotic spindleTubulin beta-2B chainHomo sapiens (human)
Schaffer collateral - CA1 synapseTubulin beta-2B chainHomo sapiens (human)
microtubuleTubulin beta-2B chainHomo sapiens (human)
cytoplasmTubulin beta-2B chainHomo sapiens (human)
cytoplasmTubulin beta-1 chainHomo sapiens (human)
microtubule cytoskeletonTubulin beta-1 chainHomo sapiens (human)
intercellular bridgeTubulin beta-1 chainHomo sapiens (human)
extracellular exosomeTubulin beta-1 chainHomo sapiens (human)
mitotic spindleTubulin beta-1 chainHomo sapiens (human)
microtubuleTubulin beta-1 chainHomo sapiens (human)
cytoplasmTubulin beta-1 chainHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (383)

Assay IDTitleYearJournalArticle
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1172703Permeability ratio, ratio of permeability from apical to basolateral side over basolateral to apical side in human Caco2 cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID295385Growth inhibition of HT29 cells by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID386987Antifungal activity against haploid Saccharomyces cerevisiae YSH1170 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID90472Inhibitory activity against phytohemagglutininin A-induced proliferation of human lymphocytes1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis.
AID386976Antifungal activity against haploid Saccharomyces cerevisiae 1S by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1186725Cytotoxicity against human HL60 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
AID1411866Antifungal activity against fluconazole susceptible Candida albicans 0072gr in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID387004Antifungal activity against Hansenula polymorpha R3 with rgh3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID516542Lipophilicity, log P of the compound2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Fluorinated 2'-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities.
AID387003Antifungal activity against Hansenula polymorpha CTA1 with leu2 cat1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1057563Inhibition of MAO-B (unknown origin)2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Chromenylchalcones with inhibitory effects on monoamine oxidase B.
AID386977Antifungal activity against diploid Saccharomyces cerevisiae PV-2 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1833882Cytotoxicity against HEK293 cells assessed as reduction in cell viability at 31.3 to 1000 ug/ml measured after 24 hrs by resazurin dye based cell viability assay2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1557212Binding affinity to Streptococcus mutans Sortase A2019MedChemComm, Jul-01, Volume: 10, Issue:7
Targeting
AID551962Inhibition of cobalt chloride-induced HIF-1 activation expressed in mouse NIH3T3 cells after 8 hrs by luciferase reporter gene assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID1238019Anti-leishmanial activity against Leishmania amazonensis MPRO/BR/1972/M1841-LV-79 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID744717Cytotoxicity against human REH cells after 48 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID1320854Antioxidant activity assessed as DPPH free radical scavenging activity up to 500 umol/L after 60 mins2016European journal of medicinal chemistry, Oct-04, Volume: 121Do cinnamylideneacetophenones have antioxidant properties and a protective effect toward the oxidation of phosphatidylcholines?
AID387007Antifungal activity against Kluyveromyces lactis 1-6A with MATalpha uraA lys arg genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1414058Fungicidal activity against Aspergillus versicolor BAM8 ATCC 11730 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID161998Inhibitory activity against murine prostaglandin G/H synthase 1.2004Bioorganic & medicinal chemistry letters, May-17, Volume: 14, Issue:10
Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities.
AID1896717Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1414061Fungicidal activity against Trichoderma viride Pers after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1172702Apparent permeability from basolateral to apical side in human Caco2 cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID372906Antibacterial activity against Escherichia coli WF+2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
AID1105408Antibacterial activity against Bacillus thuringiensis MTCC 6941 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1238022Selectivity index, ratio of EC50 for BALB/c mouse peritoneal macrophages to EC50 for Leishmania amazonensis MPRO/BR/1972/M1841-LV-79 amastigotes2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1172707Permeability ratio, ratio of permeability from apical to basolateral side over basolateral to apical side in MDCK cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1488990Antiproliferative activity against human HCT116 cells assessed as growth inhibition after 3 days by SRB assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID1698227Effect on cell viability in human neutrophils assessed as death cell at 100 uM in presence of 5.5 mM glucose after 1 hr by Propidium staining based flow cytometric analysis (Rvb = 0.5 +/- 0.07 %)2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID586799Inhibition of Globodera pallida hatching2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity.
AID387020Antifungal activity against Hansenula polymorpha AS2 with gsh2 genotype at 20 to 30 uM after 1 day by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1105406Antibacterial activity against Klebsiella pneumoniae MTCC 7028 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1172705Apparent permeability from apical to basolateral side in MDCK cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1896718Cytotoxicity against human FHs74Int cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1062081Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 axenic amastigotes2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1414054Antifungal activity against Penicillium cyclopium Westling after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1248403Inhibition of porcine pancreatic alpha-amylase using soluble starch as substrate after 30 mins by Bernfeld method2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID1062079Cytotoxicity against mouse RAW264.7 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID744716Cytotoxicity against human Jurkat cells after 48 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID548112Inhibition of Trypanosoma cruzi triosephosphate isomerase at 100 uM after 2 hrs2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
AID1411859Antifungal activity against fluconazole resistant Candida albicans 167-1 in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1320859Antioxidant activity assessed as AAPH free radical scavenging activity by measuring trolox equivalent at 75 to 350 umol/L measured every min during 240 mins by fluorescein-based oxygen radical absorption capacity assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Do cinnamylideneacetophenones have antioxidant properties and a protective effect toward the oxidation of phosphatidylcholines?
AID386995Antifungal activity against Hansenula polymorpha 2a with arg1 leu2 ura3 cys1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1062082Antileishmanial activity against Leishmania infantum zymodeme MON-1 axenic amastigotes assessed as parasite survival after 24 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID548110Antiparasitic activity against Trypanosoma cruzi T2 epimastigotes assessed as growth inhibition at 25 uM after 5 days2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
AID1186727Cytotoxicity against human WM115 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
AID1414064Fungicidal activity against Chaetomium globosum BAM12 ATCC 6205 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1172699Cytotoxicity against MDCK cells assessed as reduction in cell viability2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1819032Antiproliferative activity against human KB cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1414056Antifungal activity against Chaetomium globosum BAM12 ATCC 6205 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID386978Antifungal activity against diploid Saccharomyces cerevisiae PV-3 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1414060Fungicidal activity against Penicillium funiculosum BAM22 ATCC 11797 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1698237Inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 5.5 mM glucose by luminol-amplified chemiluminescence method2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID1434246Anti-inflammatory activity in para-xylene-induced Kunming mouse ear-swelling model assessed as inhibition of ear swelling at 40 mg/kg, ig measured after 1 hr relative to control2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents.
AID349910Inhibition of human recombinant MAO-A assessed as hydrogen peroxide production at 20 uM2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Chalcones: a valid scaffold for monoamine oxidases inhibitors.
AID387010Antifungal activity against Hansenula polymorpha 2a with cys1 genotype with cellular density of 10'3 cells/ml at >40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1057564Inhibition of MAO-B (unknown origin) assessed as residual activity2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Chromenylchalcones with inhibitory effects on monoamine oxidase B.
AID1516901Antifungal activity against Trichophyton rubrum deltaTruMDR2 by CLSI-based microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID387014Antifungal activity against Hansenula polymorpha 2a with cys1 genotype with cellular density of 10'9 cells/ml at 40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID387009Antifungal activity against Hansenula polymorpha WT1 with cellular density of 10'3 cells/ml at >40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1062631Cytotoxicity against human U2OS cells at dual luciferase reporter gene assay EC50 after 24 hrs by MTS assay2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID1198248Antiinvasive activity against human MCF7/6 cells precultured with 9 day old chick embryo heart tissue fragment assessed as lowest concentration by chick heart invasion assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
AID44309In vitro percent inhibition of primary murine endothelial cell proliferation garnered from C57BL/6 mice infected with ectotropic virus at 3 ug/mL2003Bioorganic & medicinal chemistry letters, Jan-06, Volume: 13, Issue:1
Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin.
AID295380Cytotoxicity against human TK10 cells in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID1833871Solubility of the compound in 5% DMSO in MHB assessed as precipitation at up to 2.0 ug/ml measured over 24 hrs2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1411869Inhibition of ABC efflux pumps in fluconazole resistant Candida albicans 167-1 assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID386984Antifungal activity against haploid Saccharomyces cerevisiae D3C by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1441017Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID1411864Antifungal activity against fluconazole susceptible Candida albicans 004B1 in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1414049Antifungal activity against Aspergillus niger van Tiegen BAM4 ATCC 6275 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID548113Inhibition of Trypanosoma cruzi triosephosphate isomerase at 400 uM after 2 hrs2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
AID661075Antidiabetic activity in mouse 3T3L1 cells assessed as decrease in glucose consumption from cell culture medium using 450 mg/dL D-glucose at 30 ug/mL after 24 hrs (Rvb = 310 +/- 4 mg/dl)2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Synthesis of chalcone derivatives as potential anti-diabetic agents.
AID1693046Inhibition of porcine pancreatic lipase preincubated for 10 mins followed by 4-MUO addition and measured at 60 sec interval for 40 mins by multi plate micro plate reader2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors.
AID1172697Increase in permeability of lucifer yellow dye across human Caco2 cells2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1411848Antifungal activity against fluconazole resistant Candida albicans 167-2 by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1819029Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1441026Inhibition of thioredoxin reductase in human HCT116 cell lysate using thioredoxin as substrate at 40 to 70 uM after 16 hrs by end point insulin assay method2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID306425Antimicrobial activity against Mycobacterium tuberculosis H37Rv at 100 ug/ml assessed as reduction of relative light units2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives.
AID1105381Antibacterial activity against Xanthomonas oryzae ITCC B-47 assessed as as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1172710Ratio of apparent permeability from basolateral to apical side in MDCK cells to apparent permeability from basolateral to apical side in human Caco2 cells2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID452430Antiproliferative activity against human K562 cells after 5 days by MTT assay2009Bioorganic & medicinal chemistry, Nov-15, Volume: 17, Issue:22
Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
AID1768349Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI cells assessed as inhibition of H2O2 production using kynuramine as substrate preincubated for 5 mins followed by substrate addition by Amplex Red reagent based fluorescence analy2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1062077Antileishmanial activity against Leishmania infantum zymodeme MON-1 axenic amastigotes assessed as parasite survival after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1414052Antifungal activity against Penicillium funiculosum BAM22 ATCC 11797 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1441014Inhibition of recombinant rat liver thioredoxin reductase after 30 mins by DTNB reduction assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID1292018Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
AID1172701Apparent permeability from apical to basolateral side in human Caco2 cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1461518Inhibition of bovine milk xanthine oxidase at 1000 uM pre-incubated for 30 mins followed by xanthine addition and measured every 30 secs for 5 mins by spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
AID387022Mutagenic activity in Saccharomyces cerevisiae PV-3 at 35 ug/ml preincubated for 3 days at 30 degC before streaking onto YPD media plates2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1896719Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1328770Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM by UV-Vis spectrophotometric analysis2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.
AID1062643Inhibition of Wnt3A/beta-catenin signaling in HEK293 cells at 10 uM after 24 hrs by firefly/renilla dual luciferase reporter gene assay relative to vehicle-treated control2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID1543105Antitrypanosomal activity against Trypanosoma cruzi Y trypomastigotes infected in LLC-MK2-ATCC CCL7 cells assessed as reduction in parasite growth incubated for 24 hrs by Alamar blue dye based assay2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
AID387000Antifungal activity against Hansenula polymorpha AS1 with arg1 gsh2delta genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386999Antifungal activity against Hansenula polymorpha MC1 with met2 cys1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID666994Cytotoxicity against human HepG2 cells assessed as cell viability at 25 uM after 48 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors.
AID386980Antifungal activity against haploid Saccharomyces cerevisiae 2180 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1292019Inhibition of rat liver thioredoxin reductase after 60 mins by DTNB reduction assay in presence of NADPH2016European journal of medicinal chemistry, Jun-10, Volume: 115Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
AID1062644Inhibition of Wnt3A/beta-catenin signaling in HEK293 cells at 5 uM after 24 hrs by firefly/renilla dual luciferase reporter gene assay relative to vehicle-treated control2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID1833876Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 250 ug/ml measured after 24 hrs by disc diffusion method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1411871Inhibition of ABC efflux pumps in fluconazole susceptible Candida albicans 002B1 assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1238020Selectivity index, ratio of EC50 for BALB/c mouse peritoneal macrophages to EC50 for Leishmania amazonensis MPRO/BR/1972/M1841-LV-79 promastigotes2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1105397Antioxidant activity assessed as DPPH free radical scavenging activity after 20 min by UV-Vis spectrophotometric analysis2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1062076Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 axenic amastigotes after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID387011Antifungal activity against Hansenula polymorpha AS1 with gsh1 genotype with cellular density of 10'3 cells/ml at >40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID313634Blockade of human K+ channel in HEK293 cells assessed as inhibition of outward delayed rectifying K+ current at 10 uM2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Sulfonate chalcone as new class voltage-dependent K+ channel blocker.
AID386979Antifungal activity against haploid Saccharomyces cerevisiae 1169 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1768346Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID586798Toxicity against Globodera rostochiensis2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity.
AID1142531Inhibition of BChE (unknown origin) using BCh iodide as substrate preincubated for 15 mins prior to substrate addition measured after 10 mins by Ellman's method2014European journal of medicinal chemistry, Jun-10, Volume: 80Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.
AID586801Nematocidal activity against Caenorhabditis elegans assessed as mortality on day 32011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity.
AID351910Antiamnesic activity against Entamoeba histolytica HM-1:IMSS after 72 hrs by trypan blue exclusion method2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives and evaluation of their antiamoebic activity.
AID1411862Antifungal activity against fluconazole susceptible Candida albicans 003gr in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID606521Induction of Nrf2-mediated GCLM gene expression in human BEAS2B cells at 10 uM after 16 hrs by RT-PCR analysis relative to untreated control2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.
AID1411870Inhibition of ABC efflux pumps in fluconazole resistant Candida albicans 167-2 assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID387012Antifungal activity against Hansenula polymorpha AS2 with gsh2 genotype with cellular density of 10'3 cells/ml at >40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID226858Inhibition of TNF-alpha-induced VCAM-1 expression2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.
AID386994Antifungal activity against Hansenula polymorpha WA1 with ade1 leu2 gsh1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1411855Antifungal activity against fluconazole susceptible Candida albicans 0079gr by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1896715Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID372907Antibacterial activity against Staphylococcus aureus Rosenbach 209 after 48 hrs by agar well diffusion method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
AID1328768Antibacterial activity against Streptococcus pyogenes ATCC 12358 after 24 hrs by well diffusion method2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.
AID387006Antifungal activity against Kluyveromyces lactis 2-18B with MATalpha metA1 ura3 leu2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID89118Concentration required to inhibit 50% growth of human Molt 4/C8 T-lymphocyte cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID1833884Ratio of MIC for antimicrobial activity against Staphylococcus aureus ATCC 25923 to IC50 for inhibition of Staphylococcus aureus sortase A using Abz-LPETGK(Dnp)-NH2 fluorescent peptide as substrate2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID428019Growth inhibition of human HL60 cells at 1 uM after 72 hrs by trypan blue exclusion assay2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells.
AID1896711Inhibition of human mitochondrial HSP60 expressed in Escherichia coli Rosetta 2 (DE3) cells/human mitochondrial HSP10 expressed in Escherichia coli Rosetta 2 (DE3) pLysS cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID386996Antifungal activity against Hansenula polymorpha 2b with arg1 ade1 leu2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID670957Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 at 256 ug/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID1419579Cytotoxicity in human BT20 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID1543106Cytotoxicity in mouse NCTC-929 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
AID1411858Antifungal activity against fluconazole resistant Candida albicans A171 in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1419577Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID1292020Inhibition of rat liver thioredoxin reductase after 30 mins by DTNB reduction assay in presence of NADPH2016European journal of medicinal chemistry, Jun-10, Volume: 115Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
AID1238028Selectivity index, ratio of EC50 for BALB/c mouse peritoneal macrophages to EC50 for Trypanosoma cruzi Y epimastigotes2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1414059Fungicidal activity against Paecilomyces variotii BAM19 ATCC 18502 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID386990Antifungal activity against Hansenula polymorpha WT2 with ade1 met6 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1411853Antifungal activity against fluconazole susceptible Candida albicans 004gr by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1238025Anti-leishmanial activity against Leishmania infantum MHOM/BR/72 amastigotes infected in BALB/c mouse peritoneal macrophages assessed as reduction in the infection index incubated for 24 hrs by Giemsa staining method2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1419581Cytotoxicity in human DU145 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID744715Cytotoxicity against human HUVEC cells after 24 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID1768351Selectivity index, ratio of inhibition of recombinant human MAO-A to inhibition of recombinant human MAO-B2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1105405Antibacterial activity against Staphylococcus aureus MTCC 3160 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID586800Inhibition of Globodera rostochiensis hatching2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity.
AID744714Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID386985Antifungal activity against haploid Saccharomyces cerevisiae FY4 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID744712Inhibition of bovine brain tubulin assembly after 20 mins by spectrophotometric analysis2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID1062639Inhibition of Wnt3A/beta-catenin signaling-mediated Tcf4 transcriptional activity in human U2OS cells at dual luciferase reporter gene assay EC50 after 24 hrs by FOPglow reporter gene assay2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID1062645Inhibition of Wnt3A/beta-catenin signaling in HEK293 cells at 1 uM after 24 hrs by firefly/renilla dual luciferase reporter gene assay relative to vehicle-treated control2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID1238029Cytotoxicity against BALB/c mouse peritoneal macrophages incubated for 24 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1819033Antiproliferative activity against human KB-VIN cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1348957Activation of Nrf2 (unknown origin) expressed in human HepG2 cells at 15 uM after 5 hrs by ARE-driven luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID386993Antifungal activity against Hansenula polymorpha CD3 with ade1 leu2 cds3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1511071Induction of apoptosis in human K5622019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID666993Cytotoxicity against human HepG2 cells assessed as cell viability at 3.13 uM after 48 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors.
AID92134Evaluation for cytotoxicity to human tumor cell lines.1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID1062084Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1411852Antifungal activity against fluconazole susceptible Candida albicans 003gr by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1419585Cytotoxicity in human CRL1459 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID1328766Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 24 hrs by well diffusion method2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.
AID351911Safety index, ratio of IC50 for human kidney epithelial cells to IC50 for Entamoeba histolytica HM-1:IMSS2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives and evaluation of their antiamoebic activity.
AID1441016Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID666990Antiamnesic activity against Entamoeba histolytica HM1:IMSS after 72 hrs by microdilution method2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors.
AID386989Antifungal activity against Hansenula polymorpha WT1 with ade1 ura3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386991Antifungal activity against Hansenula polymorpha CD1 with ade1 leu2 cds1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1516902Inhibition of fatty acid synthase in Trichophyton rubrum ATCC MYA31082019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1557214Antibiofilm activity against Streptococcus mutans assessed as inhibition of biofilm formation at 250 uM on saliva-coated glass slides relative to control2019MedChemComm, Jul-01, Volume: 10, Issue:7
Targeting
AID144377Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.1998Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.
AID1411861Antifungal activity against fluconazole susceptible Candida albicans 002B1 in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1461520Antioxidant activity assessed as ABTS free radical scavenging activity by measuring trolox equivalents after 6 mins2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
AID1411860Antifungal activity against fluconazole resistant Candida albicans 167-2 in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1768345Antiproliferative activity against human A2780 cells assessed as cell growth inhibition measured after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1414053Antifungal activity against Trichoderma viride Pers after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1768347Antiproliferative activity against human MSTO-211H cells assessed as cell growth inhibition measured after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID744709Antimitotic activity in human HeLa cells assessed as tubulin intensity after 24 hrs by Hoechst 33342 staining2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID1411878Inhibition of ergosterol biosynthesis in fluconazole susceptible Candida albicans ATCC 90028 at 0.5 to 1 times MIC relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1167300Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
AID387016Antifungal activity against Hansenula polymorpha AS2 with gsh2 genotype with cellular density of 10'9 cells/ml at 40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1488991Antiproliferative activity against human CAL51 cells assessed as growth inhibition after 3 days by SRB assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID744708Antimitotic activity in human HeLa cells assessed as increase in phosphohistone H3 level after 24 hrs by Hoechst 33342 staining2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID606613Induction of Nrf2-mediated NQO1 gene expression in human BEAS2B cells at 10 uM after 16 hrs by RT-PCR analysis relative to untreated control2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.
AID666991Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors.
AID1238026Selectivity index, ratio of EC50 for BALB/c mouse peritoneal macrophages to EC50 for Leishmania infantum MHOM/BR/72 amastigotes2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1172700Cytotoxicity against human Caco2 cells assessed as reduction in cell viability2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID386988Antifungal activity against haploid Saccharomyces cerevisiae YSH1171 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1419583Cytotoxicity in human OV2008 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID387005Antifungal activity against Hansenula polymorpha CRD2 with leu2 CDR2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID387002Antifungal activity against Hansenula polymorpha AU05 with ade3 ura3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1411867Antifungal activity against Candida albicans ATCC 90028 in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1062083Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 promastigotes after 24 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1698229Effect on cell viability in human neutrophils assessed as death cell at 100 uM in presence of 30 mM glucose after 1 hr by Propidium staining based flow cytometric analysis (Rvb = 0.8 +/- 0.13 %)2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID1172704Efflux ratio, ratio of permeability from basolateral to apical side over apical to basolateral side in human Caco2 cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1238021Anti-leishmanial activity against Leishmania amazonensis MPRO/BR/1972/M1841-LV-79 amastigotes infected in BALB/c mouse peritoneal macrophages assessed as reduction in the infection index incubated for 24 hrs by Giemsa staining method2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID387019Antifungal activity against Hansenula polymorpha AS1 with gsh1 genotype at 20 to 30 uM after 1 day by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1768352Cytotoxicity against human MET5A cells assessed as cell growth inhibition after 72 hrs by trypan blue assay2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID744718Cytotoxicity against mouse L1210 cells after 24 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID295386Growth inhibition of HK2 cells by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID1411856Antifungal activity against fluconazole susceptible Candida albicans 0072gr by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1105385Antifungal activity against Rhizoctonia solani ITCC 5563 by food poisoning method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1238023Anti-leishmanial activity against Leishmania infantum MHOM/BR/72 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1328767Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by well diffusion method2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.
AID1411849Antifungal activity against fluconazole resistant Candida albicans A171 by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID386982Antifungal activity against diploid Saccharomyces cerevisiae 29a by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1172698Increase in permeability of lucifer yellow dye across MDCK cells2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1819031Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1172706Apparent permeability from basolateral to apical side in MDCK cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID670950Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 256 ug/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID386997Antifungal activity against Hansenula polymorpha D22 with arg1/arg1 ade1/ADE1 leu2/leu2 URA3/ura3 CYS1/cys1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID372908Antibacterial activity against Staphylococcus aureus Rosenbach 209 after 24 hrs by serial dilution method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
AID1511072Inhibition of tubulin polymerization (unknown origin)2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID1414063Fungicidal activity against Aureobasidium pullulans BAM10 ATCC 9348 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID586797Toxicity against Globodera pallida2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity.
AID1411863Antifungal activity against fluconazole susceptible Candida albicans 004gr in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1411874Inhibition of ABC efflux pumps in fluconazole susceptible Candida albicans 004B1 assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1244035Antimicrobial activity against Trichophyton rubrum with deltaTruMDR2 mutation2015European journal of medicinal chemistry, Aug-28, Volume: 101Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.
AID387015Antifungal activity against Hansenula polymorpha AS1 with gsh1 genotype with cellular density of 10'9 cells/ml at 40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID310826Growth inhibition of Leishmania braziliensis promastigotes2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
A review of anti-infective and anti-inflammatory chalcones.
AID1896720Selectivity index, ratio of CC50 for cytotoxicity against non-cancerous cells to EC50 for cytotoxicity against human HCT-116 cells2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID306424Antimicrobial activity against Mycobacterium tuberculosis H37Rv at 50 ug/ml assessed as reduction of relative light units2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives.
AID1411851Antifungal activity against fluconazole susceptible Candida albicans 002B1 by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1698242Inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 30 mM glucose by luminol-amplified chemiluminescence method2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID44310In vitro percent inhibition of primary murine endothelial cell proliferation garnered from C57BL/6 mice infected with ectotropic virus at 6 ug/mL2003Bioorganic & medicinal chemistry letters, Jan-06, Volume: 13, Issue:1
Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin.
AID1172708Permeability ratio, ratio of permeability from basolateral to apical side over apical to basolateral side in MDCK cells at 50 uM over 2 hrs by isocratic reverse phase HPLC method2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID387013Antifungal activity against Hansenula polymorpha WT1 with cellular density of 10'9 cells/ml at 40 uM by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1198246Antiinvasive activity against human MCF7/6 cells precultured with 9 day old chick embryo heart tissue fragment at 0.1 micromol/l by chick heart invasion assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
AID1411850Antifungal activity against fluconazole resistant Candida albicans 167-1 by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID666992Selectivity index, ratio of IC50 for human HepG2 cells to IC50 for Entamoeba histolytica HM1:IMSS2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors.
AID443496Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by luciferase reporter gene assay2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
AID655021Antagonist activity at androgen receptor in human LNCAP cells assessed as decrease in prostate specific antigen mRNA level at 2.5 uM after 20 hrs by real time RT-PCR analysis relative to control2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Methoxychalcone inhibitors of androgen receptor translocation and function.
AID744710Antimitotic activity in human HeLa cells assessed as cell density loss after 24 hrs by Hoechst 33342 staining2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID1062080Antileishmanial activity against Leishmania infantum zymodeme MON-1 promastigotes assessed as parasite survival after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1488989Antiproliferative activity against human HCT116 cells at 50 uM after 3 days by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID387001Antifungal activity against Hansenula polymorpha M4 with met4 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1105386Antifungal activity against Athelia rolfsii ITCC 6181 by food poisoning method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1698231Effect on cell viability in human neutrophils assessed as decrease in cell viability at 50 uM after 1 hr by Propidium staining based flow cytometric analysis2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID351909Cytotoxicity against human kidney epithelial cells after 44 hrs by MTT assay2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives and evaluation of their antiamoebic activity.
AID283848Growth inhibition of Candida albicans Berhaut 62I by agar cup method2007European journal of medicinal chemistry, Jan, Volume: 42, Issue:1
Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
AID1414051Antifungal activity against Paecilomyces variotii BAM19 ATCC 18502 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID88789Concentration required to inhibit 50% growth of Human CEM T-lymphocytes cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID1833873Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1292016Inhibition of human recombinant dihydrofolate reductase using dihydrofolate as substrate measured every 30 secs over 6 mins by UV/visible spectrophotometer in presence of NADPH2016European journal of medicinal chemistry, Jun-10, Volume: 115Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
AID1833877Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 500 ug/ml measured after 24 hrs by disc diffusion method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1292017Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
AID1441021Inhibition of DHFR in human HCT116 cell lysate assessed as reduction in conversion of DHF to THF at 0.0001 to 1 uM after 16 hrs2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID349916Selectivity index, ratio of inhibition of human recombinant MAO-A at 20 uM or 50 uM to IC50 for human recombinant MAO-B2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Chalcones: a valid scaffold for monoamine oxidases inhibitors.
AID744711Antimitotic activity in human HeLa cells assessed as chromatin condensation after 24 hrs by Hoechst 33342 staining2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID1469806Cysteamine reactivity of the compound in TRIS-HCL assessed as second order rate constant at 40 uM and pH 7.42017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID387017Antifungal activity against Hansenula polymorpha WT1 at 20 to 30 uM after 1 day by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1896709Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1105384Antibacterial activity against Erwinia chrysanthemi ITCC B-40 assessed as as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID150684Inhibition of proliferation of murine P388 cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID160570Inhibitory activity against murine Prostaglandin G/H synthase 2.2004Bioorganic & medicinal chemistry letters, May-17, Volume: 14, Issue:10
Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities.
AID1411873Inhibition of ABC efflux pumps in fluconazole susceptible Candida albicans 004gr assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1833878Antimicrobial activity against Staphylococcus aureus MRSA ATCC 43300 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1244252Antiinvasive activity in human MCF7/6 cells assessed as Cmin for progressive occupation of chicken precultured heart tissue fragments after 8 days by chick heart invasion assay2015European journal of medicinal chemistry, Aug-28, Volume: 1014-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model.
AID1186726Cytotoxicity against human NALM6 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
AID1062085Antileishmanial activity against Leishmania infantum zymodeme MON-1 promastigotes assessed as parasite survival after 24 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID1244034Antimicrobial activity against wild type Trichophyton rubrum MYA31082015European journal of medicinal chemistry, Aug-28, Volume: 101Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.
AID1441015Inhibition of recombinant rat liver thioredoxin reductase after 60 mins by DTNB reduction assay2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID1328771Antioxidant activity assessed as H2O2 free radical scavenging activity at 100 uM by UV-Vis spectrophotometric analysis2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.
AID1414062Fungicidal activity against Penicillium cyclopium Westling after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1419578Cytotoxicity in human ZR-75-1 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID1411876Inhibition of ABC efflux pumps in fluconazole susceptible Candida albicans 0072gr assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1411865Antifungal activity against fluconazole susceptible Candida albicans 0079gr in presence of fluconazole by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID295381Cytotoxicity against human MCF7 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID295383Growth inhibition of TK10 cells by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID1441024Inhibition of thioredoxin reductase in human HCT116 cell lysate using thioredoxin as substrate at 0.0001 to 1 uM after 16 hrs by end point insulin assay method2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID659236Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 24 hrs by HPLC analysis relative to control2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
A synthetic chalcone as a potent inducer of glutathione biosynthesis.
AID283849Antifungal activity against Candida albicans Berhaut 62I in meat-pepton broth2007European journal of medicinal chemistry, Jan, Volume: 42, Issue:1
Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
AID1833880Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1244036Inhibition of Trichophyton rubrum FAS2015European journal of medicinal chemistry, Aug-28, Volume: 101Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.
AID387018Antifungal activity against Hansenula polymorpha 2a with cys1 genotype at 20 to 30 uM after 1 day by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1411854Antifungal activity against fluconazole susceptible Candida albicans 004B1 by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID387021Stability of compound in liquid YPD media after 48 hrs by UV spectrophotometry2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386983Antifungal activity against haploid Saccharomyces cerevisiae Sigma 1278b by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID551964Cytotoxicity against mouse NIH/3T3 cells assessed as cell viability after 8 hrs2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID420737Inhibition of tubulin polymerization2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
AID1411875Inhibition of ABC efflux pumps in fluconazole susceptible Candida albicans 0079gr assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID255211Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
AID255774In vitro antimalarial activity against Plasmodium falciparum 3D72005Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
Conformationally restricted anti-plasmodial chalcones.
AID1328772Antiinflammatory activity in human RBC at 10 to 500 uM by membrane stabilization method2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.
AID6764Inhibitory activity against murine lipoxygenase-2.2004Bioorganic & medicinal chemistry letters, May-17, Volume: 14, Issue:10
Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities.
AID1833874Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by CLSI based agar dilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1896716Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID386981Antifungal activity against diploid Saccharomyces cerevisiae 1a by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID313629Blockade of human K+ channel in HEK293 cells assessed as inhibition of outward delayed rectifying K+ current2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Sulfonate chalcone as new class voltage-dependent K+ channel blocker.
AID1896712Inhibition of refolded rhodanese reporter enzyme (unknown origin)2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID99076Concentration required to inhibit 50% growth of L1210 leukemia cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID387023Mutagenic activity in Saccharomyces cerevisiae PV-2 at 35 ug/ml preincubated for 3 days at 30 degC before streaking onto YPD media plates2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1411857Antifungal activity against Candida albicans ATCC 90028 by CLSI protocol based broth microdilution method2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1896713Inhibition of refolded MDH reporter enzyme (unknown origin)2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1516923Inhibition of fatty acid synthase in Trichophyton rubrum deltaTruMDR22019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID321179Inhibition of thrombin-induced platelet aggregation in human blood by turbidimetric method2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
AID1419586Cytotoxicity in HEK293 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID89021Inhibition of the production of Interleukin-1-beta from human peripheral blood monocytes stimulated with lipopolysaccharide (LPS)1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis.
AID1414057Fungicidal activity against Aspergillus niger van Tiegen BAM4 ATCC 6275 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1320850Antioxidant activity assessed as inhibition of fenton reaction-mediated PLPC peroxidation by measuring ratio of oxidized PLPC/unmodified PLPC at 1 mg/ml incubated in dark for 1 hr to 7 days by mass spectroscopic analysis2016European journal of medicinal chemistry, Oct-04, Volume: 121Do cinnamylideneacetophenones have antioxidant properties and a protective effect toward the oxidation of phosphatidylcholines?
AID664497Cytotoxicity against mouse L929 cells after 72 hrs by resazurin assay2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
AID1896714Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1198243Antiinvasive activity against human MCF7/6 cells precultured with 9 day old chick embryo heart tissue fragment at 100 micromol/l by chick heart invasion assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
AID386992Antifungal activity against Hansenula polymorpha CD2 with ade1 leu2 cds2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1414050Antifungal activity against Aspergillus versicolor BAM8 ATCC 11730 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1768350Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI cells assessed as inhibition of H2O2 production using kynuramine as substrate preincubated for 5 mins followed by substrate addition by Amplex Red reagent based fluorescence analy2021ACS medicinal chemistry letters, Jul-08, Volume: 12, Issue:7
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B.
AID1833881Inhibition of Staphylococcus aureus sortase A using Abz-LPETGK(Dnp)-NH2 fluorescent peptide as a substrate assessed as substrate cleavage measured over 60 mins by FRET assay2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID295384Growth inhibition of MCF7 cells by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID1833879Antimicrobial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1819030Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by SRB assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Chemical Space Expansion of Flavonoids: Induction of Mitotic Inhibition by Replacing Ring B with a 10π-Electron System, Benzo[
AID1896710Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dRho refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1105404Antibacterial activity against Pseudomonas aeruginosa MTCC 2581 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1062642Inhibition of Wnt3A/beta-catenin signaling in HEK293 cells at 20 uM after 24 hrs by firefly/renilla dual luciferase reporter gene assay relative to vehicle-treated control2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID1411868Inhibition of ABC efflux pumps in fluconazole resistant Candida albicans A171 assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1698247Ratio of IC50 for inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 30 mM glucose to IC50 for inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 5.5 m2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID1244039Inhibition of Saccharomyces cerevisiae chitin synthase-12015European journal of medicinal chemistry, Aug-28, Volume: 101Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.
AID1198245Antiinvasive activity against human MCF7/6 cells precultured with 9 day old chick embryo heart tissue fragment at 1 micromol/l by chick heart invasion assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
AID1461521Antioxidant activity assessed as DPPH free radical scavenging activity incubated for 30 mins at 2000 uM2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
AID100427Tested in vitro for anti-leishmanial activity against Leishmania donovani1998Journal of medicinal chemistry, Nov-19, Volume: 41, Issue:24
Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis.
AID1105407Antibacterial activity against Bacillus pumilus MTCC 2466 assessed as growth inhibition at 100 ug/disk after 24 hr by disk diffusion method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID386986Antifungal activity against haploid Saccharomyces cerevisiae 10560-6B by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID86838In vitro antimitotic activity against HeLa cells after 6 hours exposure1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
Chalcones: a new class of antimitotic agents.
AID1320852Antioxidant activity assessed as inhibition of fenton reaction-mediated PLPC peroxidation by measuring ratio of dMPC/unmodified PLPC at 1 mg/ml incubated in dark for 1 hr to 7 days by mass spectroscopic analysis2016European journal of medicinal chemistry, Oct-04, Volume: 121Do cinnamylideneacetophenones have antioxidant properties and a protective effect toward the oxidation of phosphatidylcholines?
AID659235Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 6 hrs by HPLC analysis relative to control2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
A synthetic chalcone as a potent inducer of glutathione biosynthesis.
AID1062078Therapeutic index, ratio of TC50 for mouse RAW264.7 cells to EC50 for Leishmania infantum zymodeme MON-1 promastigotes after 48 hrs2014Bioorganic & medicinal chemistry, Feb-01, Volume: 22, Issue:3
Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
AID586802Nematocidal activity against Caenorhabditis elegans assessed as inhibition of reproduction on day 32011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity.
AID1488988Antiproliferative activity against human HCT116 cells at 25 uM after 3 days by SRB assay relative to control2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
AID1328769Antibacterial activity against Staphylococcus aureus ATCC 11632 after 24 hrs by well diffusion method2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.
AID1238024Selectivity index, ratio of EC50 for BALB/c mouse peritoneal macrophages to EC50 for Leishmania infantum MHOM/BR/72 promastigotes2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1419582Cytotoxicity in human PANC1 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID16448Calculated partition coefficient (clogP)2004Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.
AID1172709Ratio of apparent permeability from apical to basolateral side in MDCK cells to apparent permeability from apical to basolateral side in human Caco2 cells2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers.
AID1198244Antiinvasive activity against human MCF7/6 cells precultured with 9 day old chick embryo heart tissue fragment at 10 micromol/l by chick heart invasion assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
AID1238027Anti-trypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as parasite growth inhibition incubated for 72 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
AID1198247Antiinvasive activity against human MCF7/6 cells precultured with 9 day old chick embryo heart tissue fragment at 0.01 micromol/l by chick heart invasion assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
AID666995Cytotoxicity against human HepG2 cells assessed as cell viability at 50 to 100 uM after 48 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors.
AID1419584Cytotoxicity in human A2780 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID664496Antitrypanosomal activity against bloodstream Trypanosoma brucei 427 after 72 hrs by resazurin assay2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
AID744713Cytotoxicity against human PBMC cells after 24 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.
AID295382Cytotoxicity against human HT29 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID1411877Inhibition of ergosterol biosynthesis in fluconazole resistant Candida albicans A171 at 0.5 to 1 times MIC relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID386998Antifungal activity against Hansenula polymorpha M2 with met2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID283847Antifungal activity against Candida albicans Berhaut 62I after 24 hrs2007European journal of medicinal chemistry, Jan, Volume: 42, Issue:1
Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
AID1419587Cytotoxicity in CHO cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID548108Selectivity for Trypanosoma cruzi triosephosphate isomerase over human triosephosphate isomerase2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
AID1062641Inhibition of Wnt3A/beta-catenin signaling in HEK293 cells after 24 hrs by firefly/renilla dual luciferase reporter gene assay2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID1411872Inhibition of ABC efflux pumps in fluconazole susceptible Candida albicans 003gr assessed as reduction in energy-dependent rhodamine 6G efflux in presence of 0.1 M glucose after 25 mins by fluorescence assay relative to control2017MedChemComm, Dec-01, Volume: 8, Issue:12
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against
AID1414055Antifungal activity against Aureobasidium pullulans BAM10 ATCC 9348 after 7 days by microtiter method2018MedChemComm, Oct-01, Volume: 9, Issue:10
7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.
AID1516900Antifungal activity against Trichophyton rubrum ATCC MYA3108 by CLSI-based microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID349912Inhibition of human recombinant MAO-B assessed as hydrogen peroxide production2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Chalcones: a valid scaffold for monoamine oxidases inhibitors.
AID1419580Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 68 hrs by MTT assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach.
AID1543107Selectivity index, ratio of CC50 for cytotoxicity in mouse NCTC-929 cells to EC50 for Antitrypanosomal activity against Trypanosoma cruzi trypomastigotes infected in LLC-MK2-ATCC CCL7 cells2019Bioorganic & medicinal chemistry letters, 06-15, Volume: 29, Issue:12
Structure-activity relationship study of antitrypanosomal chalcone derivatives using multivariate analysis.
AID1348958Effect on firefly luciferase activity expressed in human HepG2 cells at low concentration after 5 hrs by luminescence assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin.
AID1244040Inhibition of Saccharomyces cerevisiae beta-1,3-glucan synthase2015European journal of medicinal chemistry, Aug-28, Volume: 101Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.
AID1062640Inhibition of Wnt3A/beta-catenin signaling in HEK293 cells after 24 hrs by firefly/renilla dual luciferase reporter gene assay relative to curcumin2014European journal of medicinal chemistry, Jan, Volume: 71Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
AID387008Antifungal activity against Kluyveromyces lactis 2-19B with MATalpha ura lys arg genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1441013Inhibition of recombinant human DHFR assessed as reduction in conversion of DHF to THF measured every 30 secs for 6 mins by UV-Vis spectrophotometric method2017Journal of medicinal chemistry, 03-09, Volume: 60, Issue:5
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.
AID1799806Tryptophan Fluorescence Assay from Article 10.1074/jbc.M803947200: \\Small neutralizing molecules to inhibit actions of the chemokine CXCL12.\\2008The Journal of biological chemistry, Aug-22, Volume: 283, Issue:34
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
AID1799680Enzyme Inhibition Assay from Article 10.1080/14756360400015231: \\Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of some variably substituted chalcones.\\2005Journal of enzyme inhibition and medicinal chemistry, Feb, Volume: 20, Issue:1
Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of some variably substituted chalcones.
AID1798967MAO Enzyme Inhibition Assay from Article 10.1021/jm801590u: \\Chalcones: a valid scaffold for monoamine oxidases inhibitors.\\2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Chalcones: a valid scaffold for monoamine oxidases inhibitors.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,959)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990165 (8.42)18.7374
1990's199 (10.16)18.2507
2000's459 (23.43)29.6817
2010's758 (38.69)24.3611
2020's378 (19.30)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials22 (1.09%)5.53%
Reviews105 (5.21%)6.00%
Case Studies1 (0.05%)4.05%
Observational0 (0.00%)0.25%
Other1,887 (93.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]